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The endothelium lines the inner surface of all blood vessels representing an important tissue 
with vital functions to mediate tissue homeostasis [1, 2]. Tissue-tissue interfaces play an critical 
role throughout the human body where endothelial cells (ECs) contribute by creating vital 
barriers with tight and adherens junctions to regulate permeability of macromolecules and 
fluids while protecting and nourishing adjacent tissue [3, 4]. They are the most prominent cell 
type to experience physical forces of shear, stretch and strain through the laminar pulsatile 
nature of the bloodstream [5, 6]. Alterations in physiological flow profiles has a strong impact 
on EC pathology contributing to diseases like atherosclerosis and coronary heart disease as 
well as inflammatory conditions [6-8]. Further, they are among the first cell types to interact 
with xenobiotics. Endothelial endocytosis and barrier regulation have profound impact on drug-
tissue interactions. Although first attempts to study EC biology under physiological conditions 
of shear stress have already been made in the 1970s, the field hast stayed very small and 
never really left focus from just investigating morphological and molecular changes on a 
cellular level for a long time. There is still the need for technological innovations and 
improvements to study EC biology, EC-epithelial and EC-nanocarrier interactions in more 
complex settings that take physiological biophysical and biochemical cues into account.
For this purpose, the Multi-Organ-Tissue-Flow (MOTiF) biochip has been invented and its 
design has been finalised during the beginning of this thesis. The objective was to develop 
handling and cellular seeding protocols for the biochip and to subsequently establish more in 
vivo-like and more complex in vitro EC culture approaches. Within the scope of this thesis, the 
biochip has been characterised for perfused EC culture. Complex co-cultures with tissue-
resident macrophages and further with murine cortical spheroids present in liver sinusoidal 
structures and at the blood-brain barrier (BBB) have been established, respectively. 
Additionally, first applications under physiological parameters of shear stress have been made. 
We focused on nanocarrier uptake profiles and microvascular endothelial barrier interaction.
Initially, perfused ECs have been characterised under low and high shear forces. Results were 
compared to standard flow chambers and static cell culture (manuscript I). The data on the 
biochip regarding EC morphology, marker expression, cytoskeletal changes and barrier 
integrity was found to be much more superior compared to the other approaches. In fact, we 
discovered that a three-dimensional (3D) perfusion of ECs benefits their biology at the most.
Immune cell recruitment is an important process and tissue-resident macrophages are 
prominent in many vessels and organs. With the newly established perfusion protocols, we 
investigated EC-macrophage-interaction influence on xenobiotics such as nanoparticles (NPs) 
(manuscript II). We chose various shear forces to represent conditions of different vascular 
beds. We gained interesting insight in shear force dependent and co-culture dependent NP 
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uptake. Most intriguing is the fact, that high flow and shear rates do not necessarily decrease 
EC-NP interactions and uptake as we initially hypothesised. Secondly macrophages had a 
profound impact and dampened endothelial NP uptake presumably due to paracrine signalling. 
Finally, in this study we could demonstrate that observations made in the perfused in vitro 
system could be found in in vivo models of mice. 
The multi-layered design of the MOTiF biochip is intentionally and favours more complex co-
cultures on several levels and in particular supports questions of barrier integrity. Hence, we 
were eager to test the culture of ECs from unique vascular beds like the microvasculature of 
the BBB. Additionally, we further developed the biochip design with an additional membrane 
enabling the immobilisation of cortical spheroids representing neural tissue (manuscript III). 
We were able to demonstrate the successful establishment of a simple perfused BBB-like 
model. We could functionally prove that inflammation induced microvascular barrier 
breakdown had profound impact on the differentiation and survival of adjacent neural tissue. 
Thus, the MOTiF biochip facilitates complex perfused co-cellular culture and crosstalk.
In a concluding study we used these insights to simulate nanocarrier delivery across the BBB. 
We investigated the influence of glutathione (GSH) functionalisation on polyplex-forming 
polymers (manuscript IV). We obtained best results for maintaining microvascular barrier 
integrity with simultaneous barrier passage capacity for GSH-decorated polyplexes with 
secondary amino-functionality. Most importantly, we could demonstrate the model’s feasibility 
to improve studies on EC-NP interaction.
Concluding the results of this thesis, the MOTiF biochip development was successfully 
completed and culture conditions for improved perfused EC cultures were established. The 
biochips’ feasibility could be demonstrated in an exemplary way with nanocarriers representing 
applications for xenobiotic screenings. Comparative analysis to studies performed in animals 
demonstrate the potential of the newly developed tool to minimize or close the data 
transferability gap between in vitro and in vivo experiments. Further, the gained insights in 
handling perfused EC cultures and the obtained results suggest various future possibilities for 
complex multi-cellular cultures to implement different microphysiological systems (MPS) with 




Endothelzellen kleiden die Oberfläche aller Blutgefäße aus und üben lebenswichtige 
Funktionen aus, mit denen sie die Homöostase des Blutgefäßgewebes regulieren [1, 2]. 
Gewebe-Grenzflächen spielen im gesamten menschlichen Körper eine wichtige Rolle und 
Endothelzellen tragen dazu bei, diese Barrieren mit Zellkontakten der tight und adherens 
junctions abzudichten. Darüber hinaus regulieren sie die Permeabilität von Makromolekülen 
und Flüssigkeiten [3, 4]. Sie stellen den prominentesten Zelltyp dar, bei dem physikalische 
Kräfte wie Scherstress, zelluläre Dehnung und Verformung durch die laminar-pulsatilen Kräfte 
des Blutstroms hervorgerufen werden [5, 6]. Darüber hinaus gehören Endothelzellen zu den 
ersten Zelltypen, die mit körperfremden Stoffen interagieren und deren Verbleib beeinflussen. 
Obwohl bereits in den 1970er Jahren physiologische Flusskulturbedingungen von 
Endothelzellen untersucht wurden, blieb das Forschungsgebiet lange Zeit sehr klein und nur 
auf die Untersuchung morphologischer und molekularer Veränderungen beschränkt. Es 
besteht demzufolge ein Bedarf an technologischen Neuerungen, um Endothelzellbiologie als 
auch Wechselwirkung mit angrenzendem Epithelgewebe und körperfremden Stoffen in einem 
komplexen physiologischen Umfeld unter Berücksichtigung biochemischer und 
biophysikalischer Parameter zu untersuchen.
Um dies zu realisieren, wurde der MOTiF-Biochip erfunden und zu Beginn dieser Arbeit in 
seinem Design finalisiert. Die Ziele waren die Entwicklung von Protokollen für das Chip-
handling und eine perfundierte Endothelzellkultur. Zellkulturen mit gewebeständigen 
Makrophagen, die die sinusoidalen Strukturen der Leber repräsentieren, und ferner mit 
kortikalen Sphäroiden, die einfache neuronale Gewebestrukturen an der Blut-Hirn-Schranke 
repräsentieren, wurden darauf aufbauend etabliert. Zusätzlich wurden erste Anwendungen 
demonstriert. Der Fokus lag hierbei auf Nanoträgerstrukturen und deren zelluläre Aufnahme 
sowie die Interaktion mit der mikrovaskulären Endothelzellbarriere der Blut-Hirn-Schranke.
Zunächst wurden Kulturprotokolle entwickelt und Endothelzellen unter niedrigen und hohen 
Scherkräften charakterisiert. Die Ergebnisse wurden mit standardisierten einkanaligen 
Biochips und statischen Zellkulturen verglichen (Manuskript I). Die aus dem MOTiF-Biochip 
gewonnenen Daten bezüglich Endothelzellmorphologie, Marker-Expression, 
Zytoskelettausbildung und endothelialer Barriereintegrität erwiesen sich als überlegener. 
Tatsächlich stellten wir fest, dass die Endothelzellen von einer dreidimensionalen Perfusion, 
welche das Chipdesign erlaubt, am besten profitieren.
Die Rekrutierung von Immunzellen ist ein wichtiger Prozess innerhalb des Blutgefäßsystems. 
Mit den neu etablierten Kulturprotokollen untersuchten wir den Einfluss von Endothelzell-
Makrophagen-Kokultur auf die Interaktion mit körperfremden Stoffen wie z.B. Nanopartikel 
(Manuskript II). Hierfür haben wie ein Spektrum verschiedener Scherstresswerte gewählt, 
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welche die Bedingungen in verschiedenen Blutgefäßen darstellen. Scherkräfte und 
Makrophagen prägten die Nanopartikelaufnahme signifikant. Am überraschendsten ist das 
Ergebnis, dass hohe Fluss- und Schergeschwindigkeiten nicht unbedingt die 
Wechselwirkungen von Nanopartikeln an Endothelzellen verringern, wie ursprünglich 
vermutet. Darüber hinaus schwächten Makrophagen die Aufnahme von Nanopartikeln durch 
das Endothel maßgeblich. Dies ist vermutlich auf parakrine Signalwege zurückzuführen. 
Schließlich konnten wir in dieser Studie zeigen, dass die in vitro gewonnenen Ergebnisse in in 
vivo-Mausversuchen nachvollzogen werden konnten.
Das Design des MOTiF-Biochips begünstigt ferner die Etablierung komplexerer Kokulturen. 
Die frei hängende Membran ermöglicht eine Zellkultur auf mehreren Ebenen und unterstützt 
insbesondere Fragestellungen der Barriereintegrität. Daher waren wir bestrebt, die Kultur von 
Endothelzellen mit besonderer Barrierefunktion wie z.B. der Blut-Hirn-Schranke zu testen. 
Dafür wurde das Biochip-Design mit einer zusätzlichen Membranebene weiterentwickelt, 
welche die Immobilisierung kortikaler Sphäroide ermöglichte (Manuskript III). Wir konnten die 
erfolgreiche Etablierung eines einfachen perfundierten Blut-Hirn-Schranke Modells 
demonstrieren und funktionell nachweisen, dass entzündliche Prozesse die mikrovaskulären 
Barriere zusammenbrechen lassen und einen tiefgreifenden Einfluss auf die Differenzierung 
und das Überleben des benachbarten Nervengewebes haben. Somit ermöglicht der MOTiF-
Biochip auch den Aufbau komplexer perfundierter Zellkulturmodelle und zelluläre 
Kommunikation.
In einer abschließenden Studie haben wir mit diesem Modell die Passage von Glutathion-
funktionalisierten Nanoträgersystemen über die Blut-Hirn-Schranke simuliert (Manuskript IV). 
Die besten Ergebnisse für die Aufrechterhaltung der mikrovaskulären Barriereintegrität bei 
gleichzeitiger Fähigkeit die Barriere zu passieren, erhielten wir für Glutathion-funktionalisierte 
Polyplexe mit sekundärer Aminfunktionalität. Weiterhin konnten wir damit die Nützlichkeit zur 
Evaluierung von Endothelzell-Nanopartikel-Interaktionen demonstrieren.
Zusammengefasst wurde die Etablierung des MOTiF-Biochips für endotheliale perfundierte 
Mono- und Kozellkulturen erfolgreich umgesetzt. Die spezifische Anwendung der Systeme 
konnte beispielhaft an Studien mit Nanoträgerstrukturen demonstriert werden, die eine 
mögliche Form von Wirkstoffapplikationen und Therapieformen darstellen. Vergleichbare 
Ergebnisse zu tierexperimentellen Studien von Kollegen zeigen das Potenzial des neu 
entwickelten Biochips, die Lücke bei der Datenübertragung aus in vitro-Versuchen in in vivo-
Experimente zu minimieren oder zu schließen. Darüber hinaus belegen die gewonnenen 
Erkenntnisse im Umgang mit perfundierten Endothelzellkulturen und die erzielten Ergebnisse 
aus den multizellulären Versuchen, dass mit Hilfe des MOTiF-Biochips innovative, komplexe 





The endothelium is a thin layer of cells lining the inner lumen of both blood and lymphatic 
vessels in the human body [1, 2, 4]. It is comprised of ECs and the subendothelium, i.e. 
primarily extracellular matrix (ECM) proteins like collagen, fibronectin, laminin, 
glycosaminoglycans and von Willebrand factor (vWf), all secreted by ECs [2]. With 
approximately 1 x 1013 cells yielding a total mass of approximately 1 kg and a surface area of 
approximately 5,000 m² it is one of the largest tissues within the human body [1, 2]. Its main 
functions are the regulation of blood vessel barrier integrity, vasomotor tone, organisation of 
angiogenesis, the mediation and regulation of immune cell trafficking and inflammation, and 
the regulation of coagulation [1, 2, 9]. Hence, a healthy endothelium is inevitable for 
maintaining body homeostasis. EC dysfunction contributes to a variety of pathological 
conditions, mainly cardiovascular diseases (atherosclerosis, hypertension, allograft 
vasculopathy), diabetes, sepsis and associated inflammatory syndromes [1, 2]. 
Moreover, the endothelium and its associated ECM provide a site- and time-specific regulation 
of various molecular processes through the secretion of soluble factors into the blood stream 
[9]. Additionally, they are further characterised by a high degree of plasticity [1]. Both features 
cause a phenomenon to be known as EC heterogeneity [4] and strongly contributing to organ-
specific microenvironments [10]. In consequence, the endothelium is legitimately discussed to 
classify as an organ [2, 4, 11].
1.1.1 Endothelial cells form a biologically active monolayer
ECs are flattened, rhomboid cells and grow physiologically as monolayer [2]. Although ECs 
can differ significantly in protein and gene expression along the vascular tree, the majority of 
ECs share common ultrastructural characteristics like Weibel-Palade bodies (WPBs), 
fenestrae, caveolae, vesiculo-vacuolar organelles and trans-endothelial channels [9, 10, 12, 
13]  as well as immunohistochemical marker proteins like CD31 (PECAM-1), CD144 (VE-
Cadherin), vWf, vascular endothelial growth factor receptor-2 (VEGFR-2), claudin-5 and other 
cell adhesion molecules (CAMs) like ICAM-1 (CD54) and VCAM-1 (CD106), and E-selectin 
(CD62e) [2, 12, 13] (fig. 1). They also secrete bioactive molecules like NO and prostacyclin 
(PGI2) at high levels, reactive oxygen species (ROS) at low levels, endothelin (ET)-1, and 
interleukin (IL)-8 upon inflammation [2, 12]. 
Endothelial integrity is mainly mediated by CD31 at the vessel wall, together with CD144 [12]. 




chemoattractant protein (MCP)-1 chemoattractant guidance [2, 17]. Leukocyte adhesion is a 
multistep process involving endothelial cell adhesion molecules (CAMs) like ICAM-1, VCAM-1 
and selectins like E-selectin and P-selectin. Resting ECs do not consecutively express these 
molecules, but they are immediately upregulated upon injury or inflammatory stimuli [9] (fig. 1). 
Sequentially, endothelial selectins and CAMs mediate leukocyte tethering, rolling, adhesion, 
arrest and eventually extravasation into the tissue [9, 17], mainly at the site of postcapillary 
venules [4]. 
Further, ECs regulate blood fluidity [11] and set vascular tone via NO, prostacyclin and ET-1 
secretion [18, 19]. The first two phenomena act in a vasodilative way and inhibit platelet 
activation, the latter one act in a vasoconstrictive manner [19]. 
Taken together, the endothelium is a highly active tissue with a variety of different functions to 
regulate and maintain homeostasis both locally and systemically. Thus, in this thesis two 
important aspects of EC biology are introduced in more detail: the endothelial barrier and 
endothelial mechanosensitivity.
1.1.2 Endothelial cells form a selective barrier
The supply with oxygen, nutrient and hormones, and the removal of catabolites and waste 
products is regulated at the blood-tissue interface represented by the endothelium. An intact 
endothelial barrier is vital for a proper function of these processes [20]. The endothelium forms 
a tight semipermeable barrier and can be classified into continuous, (non-)fenestrated and 
discontinuous endothelial layers [12, 20]. Mainly macromolecules like albumin, transferrin and 
low density lipoprotein (LDL) are not able to translocate freely through the vessel wall [4], in 
special cases like the BBB (continuous non-fenestrated) even very small hydrophilic molecules 
[21] are prevented from translocation under physiological conditions. Macromolecular 
exchange thus mainly occurs via receptors, transporters and in vesicles [20] via clathrin-
mediated endocytosis [4] and vesiculo-vacuolar organelles [22]. Solutes pass through the 
endothelial barrier via transendothelial channels or transcytosis mediated by caveolae [4, 12]. 
1.1.2.1 Adherens and tight junctions regulate the endothelial barrier
Barrier integrity is mediated by a set of adherens and tight junctions, whereas the former are 
common to all ECs, but the latter are graduated within different sites of the vascular bed. 
Adherens junctions maintain mechanical integrity while tight junctions seal intercellular space 
[3]. Additionally, tight junctions are necessary to maintain EC polarity [4] and adherens 
junctions participate in contact-dependent growth inhibition [23]. Typically, tight junctions are 
concentrated at the apical side of a cell and adherens junctions are located below, however in 
ECs both junction proteins are found to be mixed [23, 24]. Adherens junctions are composed 
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of cadherin-catenin complexes formed by VE-Cadherin and   or  [3, 24, 25]. 
Mainly  and  bind directly to the cytoplasmic tail of VE-Cadherin, whereas  
binds those two and mediates anchorage to the peripheral actin cytoskeleton of the cell (also 
called dense peripheral band) [3, 24]. During vascular remodelling  can be further 
relocate to endothelial nuclei acting as signalling molecule [23]. Tight junctions are composed 
of integral membrane proteins like occludin, claudins and junctional adhesion molecule-A 
(JAM-A) and associated intracellular proteins like zonula occludens (ZO)-1, -2 and cingulin [23, 
26](fig. 1). Occludin participates in maintaining intercellular adhesion as well as the regulation 
of paracellular permeability [26]. Claudins comprise more than 20 proteins [26] and are thus 
the major tight junctional transmembrane proteins [23]. They function either as sealed walls or 
can form pores in the endothelial barrier [26]. Claudin-5 is specifically and highly expressed in 
endothelial tight junctions [23, 25]. The cytoplasmic tails of claudins and occludin are 
connected to ZO-1 mediating attachment to actin filaments of the cellular cytoskeleton and the 
linkage to adherens junctions [3]. Tight junctional JAM-A has mainly adhesive properties and 
is involved in leukocyte-endothelial interaction [26], two functions that are shared with PECAM-
1 [3, 23]. However, PECAM-1 is only functionally associated and not considered as a adherens 
or tight junction protein component [3].
1.1.2.2 The blood-brain barrier is a highly restrictive barrier
The manifestation of endothelial tight and adherens junctions differs within the vascular tree 
[23-25] which directly contributes to the regulation of the endothelial barrier. Peripheral beds 
show increased permeability, especially post-capillary venules [23], whereas the BBB 
represents a highly restrictive exception and is impermeable for molecules larger than 400 kDa 
[27]. Its main task is the regulation of the local environment to support neural function. The 
BBB separates the peripheral from the central transmitter pool, protects neural tissue from 
macromolecules, regulates the CNS ion composition and brain nutrition via specific 
transporters and channels and shields the CNS from neurotoxic substances (endogenous 
metabolites and xenobiotics) [28]. Claudin-1, -3 and -5, and occludin mainly contribute to the 
maintenance of the BBB tightness [21, 23, 28]. The formation of an intact physiological BBB 
further requires two adjacent cell types: a) astrocytes with end feet connecting the BBB, and 
b) pericytes secreting barrier strengthening factors [21, 23]. At the luminal site ECs of the BBB 
exhibit a low expression rate of CAMs that significantly reduces the number of adherent 
leukocytes [12]. However, it was shown that to some extent leucocytes could still transmigrate 
through the BBB via diapedesis directly through the endothelial cytoplasm avoiding endothelial 
rearrangement and opening of tight junctions [28]. 
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1.1.2.3 Endothelial barrier modulation
There are a variety of endothelial barrier-modulating factors mainly contributing to alterations 
in endothelial barrier function during pathological conditions and chronic diseases [20, 23]. In 
general, hyperpermeability is induced by vasoactive agents and cytokines upon injury and 
inflammation and can either be transient or prolonged and accompanied by leukocyte 
extravasation [20]. Histamine (trauma, burns, infection) and thrombin (thrombosis) are 
leakage-inducing agents during injury [29] and can cause transient or prolonged 
hyperpermeability associated with stress fibre formation [20]. VEGF is a cytokine commonly 
found during ischemia-reperfusion injury (common after septic shock [30]) and angiogenesis 
[29] and has also significant impact on the endothelial barrier through VE-Cadherin 
phosphorylation [12, 23]. Under inflammatory conditions, specifically during sepsis, high levels 
of the cytokines tumour necrosis factor (TNF) and  are rapidly released by leukocytes at 
target sites in tissues [31]. Both contribute to barrier breakdown via phosphorylation of the VE-
Cadherin complex [23, 32], redistribution of PECAM-1 [3], reorganization of the cellular 
cytoskeleton [31] and shedding of the endothelial glycocalyx associated with a loss in 
mechanosensing and vascular control [33]. But in contrast to the former mentioned agents, 
cytokines are generally long-lasting [3]. This is a huge problem in sepsis and associated 
inflammatory syndromes causing prolonged vascular leakage and bacterial translocation 
eventually leading to severe multiple organ dysfunction or failure [30]. 
In contrast, intended endothelial barrier modulation is important for CNS-targeted drug 
delivery. Over 20 years ago, the BBB was less well represented in academic neuroscience or 
industry programs, however, it sets the bottleneck for treating CNS disorders. A variety of 
biotechnologically manufactured large molecules like monoclonal antibodies, gene 
therapeutics and recombinant proteins do not cross the BBB [27]. Various strategies to 
overcome the BBB have been discussed such as focused ultrasound supported BBB opening 
[34], non-invasive nasal delivery [35], or receptor- and carrier-mediated transport by 
functionalised chemical drug carriers via the BBB transporter system [27, 36, 37]. This strategy, 
best described as a molecular Trojan horse, has already been tested for gene therapy strategy 
to treat Parkinson’s disease and brain cancer [38].
1.1.3 Mechanical stimulation of endothelial cells and mechanotransduction
Unlike other cell types and tissues in the human body, the endothelium is exceptionally 
exposed to mechanical stimulation through the bloodstream resulting in shear forces and 
tension that directly act upon ECs. This has extensive consequences on EC phenotype and 
functionality. Hemodynamic shear forces induce shear stress on the endothelial membrane 
with additional pressure and deformation (strain) as well as cytoskeletal manipulation (tension) 
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characteristics [5, 6]. Cellular and vessel deformations by pressure gradients result in 
distension and tension, and can be described by Laplace’s law [5]. Shear stress mainly occurs 
at the vessel wall (commonly referred to as wall shear stress), displays a frictional (tangential) 
force as a result of the blood flow, is mathematically described by Poiseuille’s law (cf. 1.3.3) 
and mainly depends on vessel diameter and blood viscosity. Typical shear stress values are 
0.1 – 0.6 Pa (also commonly found in the literature as dyn/cm²; 1 dyn/cm² = 0.1 Pa) for veins 
and 1 – 7 Pa for arteries in the human body [6]. However, the literature is still lacking 
comprehensive data sets for the human circulation, especially the microcirculation within 
organs. 
1.1.3.1 Endothelial cells phenotypically adapt to shear forces
Alterations in vessel geometry could result in three distinctive flow patterns within the human 
circulation: laminar, disturbed and turbulent (oscillatory) flow [39-41]. In the healthy vasculature 
laminar flow is predominately present but arterial bifurcations also induce turbulent and 
disturbed flow patterns [39, 41]. Shear stress and flow patterns induce tremendous adaptive 
changes on EC morphology and EC function [5, 42]. Under flow conditions ECs elongate and 
align with the direction of flow, in vivo [43-45] as well as in vitro [39, 41, 42]. This is 
accompanied with extensive remodelling of the EC cytoskeleton and the formation of F-actin 
stress fibres coaligned in the direction of flow [46-48]. Additionally, changes in integrin 
distribution can be observed and both contribute to enhanced EC adhesion under mechanical 
manipulation [5]. Laminar shear stress decreases cellular turnover [49] and inhibits apoptosis 
[50] promoting a quiescent EC layer. Endothelial CAMs are differentially and specifically 
regulated by shear stress. Under laminar shear stress ICAM-1 is upregulated [51, 52], whereas 
VCAM-1 and E-selectin are reported to be unaffected [52] or downregulated [53]. However, 
oscillatory shear stress induces enhanced expression of all three molecules and thereby 
promotes leukocyte adhesion [54]. Shear stress is known to increase the endothelial 
permeability of small and macro-molecules [41]. Further, Ca2+-specific and K+-specific ion 
channels are activated immediately upon onset of shear forces applied on ECs [5, 41]. Barrier 
shaping molecules like PECAM-1 [55], occludin and ZO-1 are upregulated by mechanical 
stimulation [56] (fig. 2). Similarly, the release of substances like NO and prostacyclin, both 
inducing flow-dependent vasodilation [5], or the release of endothelial-derived neurotransmitter 
bradykinin [57] is triggered by shear stress. 
1.1.3.2 Mechanotransduction and the mechanosensory complex
Molecules of the EC plasma membrane projecting into the luminal side of blood vessels made 
them already in early flow experiments to speculative candidates for mechanosensing and 





1.1.3.3 Pathological conditions associated with non-laminar flow patterns
Non-laminar flow patterns, mainly of turbulent / oscillatory nature, are reported to be associated 
with endothelial dysfunction [6, 39, 60]. Oscillatory flow-prone regions are arterial bifurcations 
and curvatures [6, 39, 55] with flow separation zones and recirculation [61]. They depict two 
distinctive sites of the vascular bed to be susceptible for atherosclerotic changes of the vessel 
wall [7]. Turbulent flow increases EC DNA synthesis, proliferation and turnover [40]. In this 
context, Smad 1/5 has proven to be oscillatory flow-specifically upregulated, contributing to EC 
cycle progression and it further can be found increasingly in atherosclerotic regions [60]. 
Moreover, low oscillatory flow increases CAM expression, ET-1 and ROS production, LDL 
uptake and oxidation, ECM degradation, vascular remodelling, and MCP-1 expression, all 
promoting EC - monocyte and - T-lymphocyte interaction as well as immune cell adherence 
with subsequent vascular remodelling and atherosclerotic plaque formation [39, 42, 55]. 
Similar processes induced by decelerated or altered flow patterns can be observed in venous 
pathologies like telangiectasias, reticular and varicose veins [62] and in the coronary 
microcirculation during the pathogenesis of myocardial ischemia [8]. In this context, mainly 
endothelial- and neutrophil-derived ROS decrease vasoreactivity and trigger an inflamed 
endothelium after reperfusion, known as ischemia-reperfusion injury [63], also common in 
sepsis.
1.2 Nanoparticles in clinical research
Nanoparticles are a promising new technology for drug delivery and the research area focusing 
of the improvement of these delivery tools has rapidly developed within recent years. Their 
unique properties allow the carriage and delivery of drugs to specific target sites within tissues 
[64]. The agents transported can either be classic chemical and biological drugs or biological 
material such as pDNA, mRNA or siRNA for gene therapy. Up to date, the majority of NP-
based drugs are anti-cancer and anti-inflammatory agents [65]. Drugs can either be laden onto 
the surface of the NP or they can be dissolved, entrapped, absorbed or encapsulated into the 
NP matrix [66]. The combination of small sizes and biodegradable materials support several 
advantages of NPs: targeted drug delivery with increased uptake, suitability for intravenous 
application, improved bioavailability with higher therapeutic efficacy, protection against 
enzymatic degradation, establishment of long-lasting local drug depots and reduced toxicity 
towards off-target tissues [64, 66]. Despite their benefits and broad application range, the pre-
clinical evaluation of NP uptake efficiency and biodistribution remains a major challenge to be 





drugs can be immobilized onto the surface. These different options facilitate various release 
strategies and therapeutic applications [66, 68] rendering polymeric NP application a diverse 
field. Dendritic structures have been observed in many biological systems hence their 
architecture was adapted to well-defined, regularly branched NPs (fig. 4F). Key components 
are a core, dendrons (arms) and surface-active groups for various ligand modifications and 
drug immobilization [64, 68]. In early studies with encapsulated drugs their release was difficult 
to control leading to the incorporation of degradable links and to the usage of dendronized 
polymers (linear polymers with dendrons) with enhanced circulation time [66]. Moreover, there 
are further requirements to be met for clinical applications: stability of the nanotransporter 
within blood without activation of the reticuloendothelial system (RES) as well as non-toxicity, 
non-thrombogenicity, non-immunogenicity, non-proinflammatory properties to guarantee its 
safe application as a treatment option for patients [68]. Nanoparticle shape, size and 
formulation thus represent important characteristics influencing the NP platform and its 
usability. Nanoparticles used in this thesis are polymeric NPs (manuscript II) and polyplexes 
(manuscript IV). Polymeric NPs can be formed via particle replication in nonwetting templates 
(PRINT) [75], via reversible addition-fragmentation chain transfer (RAFT) polymerization, 
polymeric self-assembly or a combination of RAFT and self-assembly [76]. Polyplexes are 
cationic polymers used for gene delivery. Positively charged polymers form complexes by 
binding negatively charged DNA while keeping a positive net charge. This allows them to still 
interact with cells and bind to their negative membranes [67].
1.2.2 Factors influencing nanoparticle uptake and biodistribution
Cellular NP uptake is either mediated actively or passively. Passive uptake is rather rare and 
most NPs enter the cells via endocytosis on four different routes: macropinocytosis, clathrin-
mediated endocytosis, caveolae-mediated endocytosis and clathrin- and caveolae-
independent endocytosis [67]. But NPs do not only interact with their designated target tissues 
or target cells. On their way through the circulation they inevitably interact with a variety of 
molecules and cells as well as they face physical conditions like shear. Among intrinsic 
properties of shape, size and charge, these extrinsic factors additionally influence NP uptake 
strongly. 
1.2.2.1 Biological traps: immune cells, protein coronas and the EPR effect
The tissue macrophages of the RES (or mononuclear phagocyte system) are of most 
importance to NP clearance [65, 77]. The RES comprises bone marrow progenitors, blood 
monocytes and tissue macrophages with focus on Kupffer cells of the liver and macrophages 
of the spleen [64]. These cells recognize opsonins adsorbed to NPs which fosters their 
phagocytosis and clearance from the blood. Especially NPs above the size of 100 nm are 
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cleared by the RES [77]. A common strategy to apply a ‘stealth mode’ to NPs is a polyethylene 
glycol (PEG) coating [64, 65, 74, 77]. Nanoparticle uptake by phagocytic cells is increased by 
the presence of serum in general and NPs adsorb serum proteins independent from their 
charge, but the final coverage may differ [67]. Interestingly, the formation of a protein corona 
suppresses the NP uptake by non-phagocytic cells as well. Proteins may shield NPs and 
prevent cellular surface receptor interaction. Even proteins with pronounced receptor-mediated 
uptake by cells do not enhance NP uptake upon binding while conserving their conformation, 
but a disruption in protein conformation might facilitate uptake rates [74]. Hence, the protein 
corona and its influence in general as well as by specific composition on the uptake of NPs 
remains an important factor that is not fully understood up to now. Additionally, to the NP 
clearance from the blood by the RES, an enhanced permeability and retention (EPR) effect 
may lead to nonspecific NP accumulation. The EPR effect is a phenomenon known from 
cancer with high accumulation of NPs within tumours [64, 77]. A high proliferation rate of ECs 
and a decreased number of pericytes render a leaky tumour vasculature with pores of several 
hundred nm in size. Nanoparticles enter the tumour tissue easily and accumulate due to an 
impaired lymphatic drainage [64, 65, 78]. The EPR effect is used for passive tumour targeting 
but requires additional NP modifications when other tissues than the tumour are of therapeutic 
interest. Hence, the EPR might lead to unspecific blood clearance of NPs decreasing final 
dosages.
1.2.2.2 Shear forces likely influence nanoparticle uptake 
The endothelial environment is highly dynamic and mainly influenced by its hemodynamic 
conditions. Thus, flow conditions are expected to influence NP interaction and uptake by ECs 
[65]. Laminar shear stress has a profound influence on endothelial biology modulating cell 
shape and size [44, 79, 80], focal adhesion [81], adhesion molecule expression [51], glycocalyx 
deposition [82, 83], barrier function [84, 85], and action of G-proteins and ion channels [57]. 
However, to date only a few studies have taken mechanical forces into account, especially 
shear stress and its impact on EC-NP interaction and uptake. The majority of studies were 
performed in static cell culture assays to evaluate NP uptake. Factors that influence NP uptake 
the most are particle composition, shear magnitude and exposure time [65]. In this context it 
is also noteworthy that differently charged NPs show unique uptake patterns under various 
shear rates [86]. Different factors of the endothelial microenvironment influence this process 
as well as each other partially, i.e. the state of the cell surface, shear stress, protein content of 
the circulation and the presence of phagocyting cells. Thus, the endothelium constitutes a 
highly complex system locally as well as throughout the vascular bed and its main components 
should be carefully considered when evaluating EC-NP interaction and uptake.
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1.2.3 Modifications of nanoparticles and applications
Directed, specific drug delivery to sites of diseased tissues (i.e. inflammation, neoplastic and 
degenerated tissue, functionally impaired signalling pathways) depicts the ultimate goal in 
nanomedicine. However, this is only achieved by unique NP formulations involving both basic 
composition and additional surface modifications to increase target specificity. Furthermore, 
NPs are subject to rapid clearance which is desired to be prevented [65]. In this context, 
polymeric NPs have gained special attention due to their stability and their simplicity to modify 
them [66]. Coating nanoparticles with surfactants or designing them from biodegradable 
polymers like PEG or polysorbate 80 prolongs their body circulation time and prevents their 
fast opsonisation associated with an increased phagocytosis rate [66, 77] and reduces their 
inflammatory potential [77]. Antibodies are predestined for targeted cellular delivery of drugs. 
For endothelial targeting, anti-VCAM-1, -ICAM-1, -PECAM-1, -E-selectin and -P-selectin 
antibodies have been successfully applied [65]. Antibodies generally constitute large proteins 
facilitating targeting and binding but might interfere with cellular uptake. Hence, smaller 
peptides or amino acids are favourable. Highly cationic cell-penetrating peptides like HIV-TAT, 
transportan or c-Jun have been used as alternatives on NPs for magnetic resonance imaging, 
bioimaging or liposomal drug delivery [77, 87].  RGD-peptides have shown to enhance integrin 
interaction and endocytosis efficiency on cancer cells [88]. Further, amino acids have also 
been identified to improve biocompatibility in treating amyloid diseases [89] and to support 
eco-friendly NP design and production [90]. In contrast, magnetic NPs have been widely used 
to explore and study cancer treatment. They qualify for easy manipulation techniques. For 
instance the desired distribution can be achieved when using active targeting of magnetic NPs 
by applying external magnetic fields for tissue specific enrichment of typically 
superparamagnetic iron oxide containing particles [77]. Variations in substrate formulation and 
composition, i.e. creating whole NP libraries, is also a common strategy to explore specificity, 
efficacy and possible side effects [91, 92]. This represents more of a reverse application 
approach to identify a NP composition hit for an application rather than optimize a sole 
formulation until it fits. This strategy has been applied in manuscript II to investigate flow-
dependent NP uptake. Moreover, small molecule (peptide) decoration has been applied in 
manuscript IV to overcome highly specialised tissue barriers in a directed way.
1.3 Biochip-based cell culture
For many decades researchers got used to culture cells ex vivo solely under static conditions 
in a classic petri dish setting. Dynamic cell culture emerged from the convergence of different 
fields from physics, chemistry and biology/medicine. The understanding of the underlying 
physical theoretical aspects of fluid properties set ground for further sophisticated 
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developments of especially analysis equipment in chemistry (gas-phase chromatography, 
high-pressure liquid chromatography) and molecular biology (high-throughput DNA 
sequencing) [93]. Adaptation of concepts of fluid flow to cell biology emerged from clinically 
relevant questions about the manifestation of atherosclerosis. For this purpose, parallel plate 
flow chambers, one of the first devices for flow-based cell culture, were invented with the 
beginning 1970s. Krueger et al. investigated MDBK cell performance under a range of minimal 
and high shear stress to shed some light onto the physical integrity of cell layers and alterations 
of cells exposed to flow [94]. The behaviour of EC morphology and EC performance under 
laminar and oscillatory or turbulent flow profiles subsequently emerged as field for first broad 
flow studies and applications [40, 44, 50, 79, 80, 95]. Later on, concepts for new and more 
complex 3D cell culture systems, tissue engineering [96] and lab-on-a-chip systems (µTAS, 
microchemical total analysis systems) emerged [97] and high-maintenance macroscale setups 
were scaled down [98]. Microfabrication processes, soft lithography and surface patterning 
techniques became quite prominent for designing perfusable cell culture devices at the 
microscale [97, 99] facilitating biochip-based cell culture and microphysiological system (MPS) 
devices. Biochip-based cell culture has the advantages of streamlining experimentation, 
recreating the physiological microenvironment in vitro and revealing cellular responses not to 
be seen in conservative cell culture settings.
1.3.1 MOTiF biochip design
The biochip used for this thesis was developed within a joint research project designated Multi-
Organ-Tissue-Flow. The MOTiF biochip comprises two cell culture cavities integrated into a 
plastic carrier in the size of a microscope slide (fig. 5A + 5C). Each cavity is separated by a 
11 µm thin porous PET membrane (8 µm pore diameter, 105 pores/ cm²) into an upper (blue) 
and a lower (orange) channel. The membrane serves as cell culture substrate (scaffold) where 
cells can be arranged and co-cultured in a layer-wise fashion on both sides. Both channels 
can be individually perfused with cell culture media (fig. 5A). Both channels, above and below 
the membrane, are rectangular-shaped to support a laminar physiologic flow profile and they 
are 0.7 mm and 0.8 mm in height, respectively (fig. 5B). The membrane provides an area of 
0.7 cm² for cell culture in MOTiF biochips version 2 (fig. 5A + 5C) and 1.1 cm² in MOTiF 
biochips version 3 (fig. 5D + 5E). Version 2 was further developed to version 3 supporting 
larger cell culture constructs. This has the advantage of culturing more cells for assay-based 




remain agile within the chip body. Surface modifications such as hydrophilization with oxygen 
plasma show only short-lasting effects [107, 108]. It was further shown that remaining PDMS 
monomers negatively influence cellular behaviour [109, 110]. PDMS has not only drawbacks 
on cell behaviour, but as ground material within flow devices of any kind it might counteract 
their intentional purpose:  ECs are exposed to different kinds of shear stress throughout the 
vasculature, hence a precise control of the applied shear stress within experimental settings is 
necessary. However, this is not supported by PDMS due to its high flexibility and deformation 
capacities [101]. Consequently, biochips designed for the studies on flow-mediated EC 
behaviour in the present thesis were made of COC (manuscript I) and PS (manuscript III and 
IV).
1.3.3 Calculation of shear values in channel systems
The MOTiF biochip design supports laminar flow conditions upon the perfusion of cells. A 
uniform, laminar flow in turn is suitable to induce shear stress on EC layers. In vivo vascular 
fluid flow is a rather complex process including pulsatile to continuous flow properties, a diverse 
vessel geometry (tapered, branched and curved) and interdependencies of physical quantities 
like fluid shear rate, fluid viscosity, vessel elasticity and radius [111]. However, the predominant 
nature of blood flow is a continuous laminar flow due to the “Windkessel” effect [112]. Laminar 
flow induced shear stress is considered to support a healthy endothelial phenotype while 
disturbed flow with low wall shear stress is associated with atherosclerosis susceptible regions 
[113]. Thus, shear stress applied in EC experimentation must be predictable and precisely 
calculable to set obtained results into the right context. Hence, channel and cavity geometries 
in microfluidic devices are kept simple [98] as it is for MOTiF biochips. Shear stress is a 
tangential force applied on the surface of ECs (fig. 6) and it is calculated based on Poiseuilles 
law (eq. 1) in vitro as well as in vivo [113, 114] by
eq. 1= 3
where  is the medium viscosity, q is the flow rate and r is the vessel radius. This equation 
applies for cylindric, duct-like structures. Most channels in microfluidic devices comprise 




where w and h are channel width and height, respectively. This case assumes infinite flat 
plates, but fluid channels are in fact confined by side walls causing a deviation of shear stress 
from eq. 2 at near-wall regions. This effect heavily depends on the cross-sectional aspect ratio
eq. 3=
where low  implies a slit-like geometry with negligible side wall effects in a two-dimensional 
model. For 3D velocity profiles within microfluidic channels, eq. 2 can be modified in a simple 
approximation to 
eq. 4= 2(
+ 1)( + 1)
with
eq. 5= 1.7 + 0.5 1.4
where n = 2 for aspect ratios  < 1/3 [98].
Another important parameter specifying the nature of the obtained flow profile at any given 
velocity is the Reynolds number, Re, which is defined by
eq. 6=
where  is the fluid density, U is the flow velocity and L the characteristic channel length. Low 
values (Re < 103) indicate a uniform laminar flow profile whereas high values (Re > 104) 
indicate a chaotic turbulent flow profile [98].
Based on eq. 1 to 6, shear stress values and corresponding flow profiles were calculated for 
the perfusion channels of the MOTiF biochip. These approximations to calculate shear stress 
hold for microfluidic in vitro applications, but not for the complex in vivo situation with branching 
and curved vessels as well as the non-Newtonian fluid nature of blood [113]. A comprehensive 







In basic research, toxicology and drug screening, animal models are elaborately and time 
consuming. Further they are lastingly challenged by ethical concerns with increasingly less 
support by the public and by the scientific community itself. About 60 years ago, William Russel 
and Rex Burch defined the principles of 3R in a publication where they made basic suggestions 
for scientific research. The background of 3R is to substitute animal experimentation 
(replacement), to decrease the number of animals being used (reduce) and to constantly 
improve scientific research techniques and tools (refine) to limit animal suffering [125]. 
Although scientists have been recognising these suggestions, they became legally approved 
just in 2010 in an EU directive (2010/63/EU) on the dealings with animals in scientific research. 
Since then, the focus on the development of new tools to fit the 3R principle has been 
intensified.
However, not only legal frameworks and governments set the tone for new innovations but 
also intrinsic motivation in the field of cell biology, biochemistry and drug development. Animal 
physiology differs significantly from human physiology, hence there is a problem of data 
transfer from animal models to prepare following clinical trials, a so-called transferability gap 
[126]. Moreover, some human diseases cannot be adequately simulated in small animal 
models like atherosclerosis or liver and lung fibrosis [127-129]. Further, standard in vitro cell 
culture does not take physiological parameters like shear forces, cyclic stretch of tissue and 
multi-cellular cross-talk sufficiently into account [126]. However, due to their inherent nature of 
forming a cellular mono-layer directly in contact with the blood stream, ECs would benefit the 
most from emulated flow properties and the resulting mechanical forces ex vivo. Additionally, 
there is a need for methods to enable microfluidically supported multi-cellular cultures as it is 
the fact that since the early 1970s the field of flow-based mono-cell culture did not evolve 
substantially in complexity during the following 30 years.  
2.2 Approach to solution
Following, in the joint research project MOTiF, a biochip for more physiologic in vitro cell culture 
was developed.
Within this thesis, the objective is to initially characterise MOTiF biochips for perfused vascular 
EC culture. The focus is to develop handling strategies for the biochip and developing protocols 
for mono-cell culture as well as cellular co-cultures. ECs culture within MOTiF biochips will be 
characterised regarding growth behaviour, typical EC marker expression, EC barrier formation 
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and how to deal with different perfusion regimes. Further, the development of perfused cellular 
co-culture and of 3D multi-cellular models will be demonstrated. Eventually, the established 
perfused cellular in vitro systems will be tested for responsiveness to inflammatory conditions 
and for their feasibility in drug screenings by the testing of different nanocarrier-systems in two 
different settings: the endothelial lining of liver sinusoidal structures and the microvascular 
endothelial BBB.
The implementation will be achieved by establishing microfluidic perfusion culture in the MOTiF 
biochips, by imaging techniques such as brightfield and immunofluorescence microscopy, by 
flow cytometry and quantification of microscopy data for cell growth, EC biomarker expression 
and modulation and nanocarrier interaction.
Eventually, the newly developed biochip tool and its characterisation for EC culture will be 
discussed in the context to support in vitro studies in a more physiological way, to support the 
further development of more complex microphysiological systems and how it bears the 
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Microfluidically supported biochip design for culture of endothelial 
cell layers with improved perfusion conditions
Raasch, M., Rennert, K., Jahn, T., Peters, S., Henkel, T., Huber, O., Schulz, I., Becker, H., 
Lorkowski, S., Funke, H. and Mosig, A. (2015)
Biofabrication 7(1): 015013
Here, we describe the development and design of the microfluidically supported MOTiF biochip 
and characterise its potential to improve EC cell culture under physiological perfusion 
conditions. The MOTiF biochip is made of Topas® and has the dimensions of a microscopic 
slide to enable its use with standard lab hardware. An integrated porous membrane serves as 
cellular scaffold separating an upper from a lower channel system. Computational fluid 
dynamic (CFD) simulations verified laminar flow conditions within the MOTiF biochip. ECs were 
subjected to bidirectional perfusion conditions and were characterised for expression of typical 
endothelial marker proteins (PECAM-1, von-Willebrand factor, ZO-1) and morphological 
adaption to flow conditions. Further, responsiveness to cytokine treatment (TNF and  was 
demonstrated based on meassurement of cell adhesion molecule (CAM) expression, related 
immune cell recruitment and adhesion as well as endothelial barrier modulation. Results were 
compared to static cell culture conditions and two-dimensional standard flow chambers. We 
found EC culture in MOTiF chips to be superior over conventional culture approaches in terms 
of cellular morphology and protein expression, which was similar to the in vivo situation. We 
conclude that improved bilateral perfusion conditions exhibit beneficial effects on perfused EC 
culture.
author contribution (80 %): Cell culture and HUVEC isolation from umbilical cords, biochip 
preparation (sterilisation, cell seeding and maintenance), evaluation of culture conditions within 
the MOTiF biochip, performing biochip perfusion experiments, calculation of shear stress 
levels, immunofluorescence staining and microscopy, cell shape index analysis, permeability 































Comparison of the uptake of methacrylate-based nanoparticles in 
static and dynamic in vitro systems as well as in vivo
Rinkenauer, A.C., Press, A. T., Raasch, M., Pietsch, C., Schweizer, S., Schwörer, S., 
Rudolph, K. L., Mosig, A., Bauer, M., Träger, A. and Schubert, U. S. (2015)
Journal of Controlled Release 216: 158-168
In this manuscript, the established microfluidic platform of our lab is tested in a first application. 
For this purpose, we performed a study comparing the uptake of methacrylate-based NPs in 
dependence of their systematically altered physicochemical properties. A well-defined 
poly((methyl methacrylate)-co-(methacrylic acid)) (PMAA) and poly((methyl methacrylate)-co-
(2-dimethylamino ethylmethacrylate)) (PDMAEMA) based NP library was chosen. The 
following basic principles to assess the suitability of the system are taken into account: (i) 
influence of NP composition regarding polymers and corresponding surface charges on uptake 
behaviour, (ii) influence of perfusion culture with different types of shear stress representing 
different sites of the human body, (iii) influence of macrophage co-culture on NP distribution 
and (iv) finally comparison of in-vitro obtained data to in-vivo systemic administration with focus 
on the liver as main xenobiotic metabolising tissue. We were able to show that increasing NP 
surface charge promotes cellular uptake by ECs in in-vitro static as well as perfusion culture. 
Furthermore, distinct applied shear stress alters in-vitro uptake behaviour significantly. 
Coculture with tissue-resident macrophages revealed a significant impairment of HUVEC NP 
uptake compared to mono-cell culture. Finally, in-vivo obtained data on polymer-dependent 
and endothelial as well as macrophage cell type specific NP uptake verify in-vitro perfused cell 
culture models as promising screening tools for NP uptake and distribution. 
author contribution (25 %): HUVEC isolation from umbilical cords, HUVEC and macrophage 
cell culture, performance of whole blood monocyte isolation, macrophage differentiation and 
fluorescence labelling, biochip preparation of HUVEC mono-cell and HUVEC-macrophage co-
culture, performing biochip NP uptake studies, immunofluorescence microscopy, quantification 
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1 Polymerizations
Table S 1: Overview of the selected RAFT polymerization conditions.
Polymer Feed ratio
 [a] Feed ratio m in g time
sample MMA/MAA CPDB/AIBN MMA MAA CPDB AIBN [h]
PMMA 100/0 1/0.25 6.007 0 0.1328 0.0246 13
P(MMA-co-MAA) 97/3 1/0.25 5.827 0.155 0.1328 0.0246 13
P(MMA-co-MAA) 95/5 1/0.25 5.707 0.258 0.1328 0.0246 13
P(MMA-co-MAA) 92.5/7.5 1/0.25 5.557 0.387 0.1328 0.0246 13
P(MMA-co-MAA) 90/10 1/0.25 5.406 0.516 0.1328 0.0246 13
P(MMA-co-DMAEMA) 80/20 1/0.25 4.806 1.033 0.1328 0.0246 12.5
[a] Molar ratio in the polymer feed solutions between MMA and MAA or DMAEMA.
1.1 Polymer characterization:













































































































































































































Figure S 1: SEC chromatograms and 1H NMR spectra’s of the final copolymers. The homopolymer PMMA was used 
as reference (adjustment of the broad backbone integral from 0.5 to 2.5 ppm to exclude impurities like water) and all 
spectra were corrected with this ratio between –OCH3 and the backbone signal of PMMA (correction factor 0.964).
2 Nanoparticle characterization
Table S 2: Zeta potential of methacrylate-based nanoparticles with concentrations of 50 µg mL-1 in type 1-water.
Nanoparticle Zeta potential [mV]
3% PMAA – 43.3
5% PMAA – 32.7
8% PMAA – 32.5
13% PMAA – 38.3







An integrative microfluidically supported in vitro model of an 
endothelial barrier combined with cortical spheroids simulates 
effects of neuroinflammation in neocortex development
Raasch, M., Rennert, K., Jahn, T., Gärtner, C., Schönfelder, G., Huber, O., Seiler, A. E. M. 
and Mosig, A. (2016)
Biomicrofluidics 10: 044102
In this manuscript we report the establishment of an integrative microfluidically supported BBB 
model of a human cerebral microvascular EC (hCMEC) layer co-cultured with brain cortical 
spheroids. The MOTiF biochip has been improved by integration of a unique second free 
hanging membrane comprising micro wells enabling spheroid immobilisation und flow 
conditions. The microvascular EC line hCMEC/D3 and cortical spheroids were adapted to a 
mutual medium formulation in a stepwise manner before chip integration and shear stress 
levels were adjusted to physiological conditions. Microvascular ECs were directly perfused, 
and cortical spheroids supplied with nutrition medium through the pores of the lower scaffold 
membrane. The microphysiological co-culture setup was characterised for expression typical 
cell marker proteins for each individual cell type and further barrier integrity was evaluated. 
Inflammatory conditions emulated by perfusion with a cytokine mixture of TNF,  interferon 
gamma  and lipopolysaccharide (LPS) resulted in an impairment of EC barrier function 
and related dedifferentiation of cortical spheroids. We conclude that the improvement of the 
MOTiF biochip design enables studies with more complex cellular arrangements helping to 
address each cell type or tissue culture condition individually. In particular, we could 
demonstrate in this study a novel tool to analyse cross-communication between the brain 
endothelial barrier and adjacent nerve tissue with focus on barrier integrity and inflammatory 
processes.
author contribution (80 %): cortical spheroid transport logistics, hCMEC cell culture and 
murine cortical spheroid differentiation, performance of medium adjustment to biochip assay 
co-culture medium, cortex model assembly, performing biochip perfusion experiments, viability 
assays, analysis and quantification of spheroid growth, permeability assays, 































Supplementary Figure 1. Technical drawing of the upper and lower parts of the biochip 
specifying the sizes of individual structures. All micro-channels have a depth of 0.4 mm. In the 
indicated zoomed sections (dashed lines) the height from the membrane to respective bonding 
foil of each part of the biochip is shown.
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Supplementary Figure 2. Scheme of the cytokine-induced leakage of the endothelial barrier 




Crossing the blood-brain barrier: Glutathione-conjugated 
poly(ethylene imine) for gene delivery
Englert, C., Trützschler, A. K., Raasch, M., Bus, T., Borchers, P., Mosig, A. S., Träger, A. and 
Schubert, U. S. (2016)
Journal of Controlled Release 241: 1-14
The targeted drug delivery to the central nervous system represents one of the major 
challenges that pharmaceutical research must deal with. Glutathione (GSH) was recently 
identified as potential candidate to facilitate receptor-mediated transcytosis of nanocarriers. 
The previously published simplified model of the BBB based in an improved MOTiF biochip 
design was tested in an application study. Different pDNA polyplex forming L-GSH-coupled 
poly (ethylene imine) (PEI) polymers were analysed regarding microvascular interaction and 
translocation. The study emphasises on (i) the influence of GSH-decorated polymer 
composition on basic polyplex characteristics, (ii) GSH loading and synthesis strategy-
dependent amino group class on cellular interaction and (iii) the ability to cross the BBB and 
deliver fluorescently labelled genetic material. We demonstrated that BBB passage depends 
on amine side chains used and GSH ratio within the polymers with improved performance for 
secondary amines. We further proofed the feasibility of GSH-coupling to enhance nanocarrier 
passage through the BBB and outline this technique as promising tool for targeted gene 
delivery to the central nervous system.
author contribution (25 %): hCMEC cell culture, preparation of biochip, preparation of 
polyplex stocks, performing biochip polyplex perfusion experiments, time-dependent sampling, 
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Figure S2. Biocompatibility. A) Relative viability of hCMEC cells after 24 h incubation with the respective 
polymers at indicated concentrations. B) Relative viability of HEK cells after 24 h incubation with the respective 
polymers at indicated concentrations.
Figure S3. Light microscopy of erythrocyte aggregation of the polymers P1, P3 and P6. PBS served as negative 
control, while bPEI (25kDa) was served as positive control. Scale bar = 20 µm.
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Figure S4. A) Hemolysis assay of erythrocytes after incubation with polymers at the indicated concentrations. 
Triton X-100 served as positive control and PBS as negative control. A value less than 2% hemolysis rate was 
classified as non-hemolytic, 2 to 5% as slightly hemolytic and values >5% as hemolytic. Values represent the mean 
± S.D. (n=3). B) Erythrocyte aggregation of the tested polymers at indicated concentrations. bPEI (25 kDa) served 
as positive control resulting in high aggregation formation and PBS as negative control. Values represent the mean 
± S.D. (n=3).









P1 450 ± 7 0.51 < 1 10.4 ± 0.5
P2 328 ± 27 0.66 < 1 4.9 ± 0.4
P3 233 ± 11 0.40 < 1 4.0 ± 1.4
P6 140 ± 23 0.58 26 28.4 ± 0.6
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P2 264 ± 11 0.35 109 ± 33 24.3 ± 1.1
Figure S7. Cellular uptake study of P1, P3 and P6 polyplexes (N/P 20) using YOYO-1abeled pDNA. hCMEC 
cells were treated in EndoGro media with polyplexes for 4 h and uptake was analyzed via flow cytometry (MFI – 
Mean fluorescence intensity). Values represents the mean ± S.D. (n=3).
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Figure S8. Cellular uptake study of P1, P3 and P6 polyplexes (N/P 20) using YOYO-1abeled pDNA. hCMEC 
cells were treated in OptiMEM with polyplexes for 4 h and uptake was analyzed via flow cytometry (MFI – Mean 
fluorescence intensity). Values represents the mean ± S.D. (n=3).
Figure S9. Transfection efficiency of copolymers P1 to P3 and P6 for adherent HEK cells in OptiMEM at 






The focus of my thesis is the establishment, characterisation and improvement of 
microfluidically perfused EC cultures within microfludically perfused MOTiF biochips. Based 
on this work a MPS recreating the BBB has been established. The perfused endothelial layers 
and the BBB model were further used in screening experiments with nanocarriers intended as 
potential novel therapeutic option of precise drug delivery. Research in human cell culture still 
relies on the use of classical petri dish approaches as standard cell culture technique. 
Physiologic conditions, especially microenvironmental cues such as shear and stretch are 
mostly neglected, though there is evidence for a need of these cues to enable physiological 
cellular behaviour in vitro [130, 131]. In examples it has been demostrated that vascular ECs 
improve morphologically [47, 79] and vascular smooth muscle cell (SMC) phenotype [132, 
133]. The in vitro exchange of metabolic and catabolic substrates is performed at intervals 
creating a non-physiological sawtooth-like change of metabolite and nutrient levels in the cell 
culture medium. Further, cellular crosstalk is often not sufficiently considered. It was shown 
that isolated vascular smooth muscle cells (SMCs) lose their contractile, fully differentiated 
phenotype in in vitro in a mono-cell culture [134], but this altered secretory SMC phenotype is 
less distinctive in endothelial co-culture [135]. Hence, a loss in paracrine signalling as well as 
cell-matrix interaction can lead to cellular dedifferentiation [136]. Due to such unwanted and to 
a certain degree uncontrollable in vitro cellular behaviour and the lack of  sophisticated models, 
more complex research and drug testing is solely achieved using cost and time consuming 
animal models, lastingly challenged by ethical values [137-140]. That there soon will be no 
common agreement on the moral dilemma how extensively animal models should be used, 
lies in the diverse nature of human beliefs as Foëx reasonably outlines [141]. However, if 
pursuing animal experimentation, the most challenging issue for researchers remains the 
transferability gap between species. Not only dose extrapolation is a matter of dispute [142], 
but approaches relying solely on animal models are challenged since translation of research 
strikingly fails. For instance only 8 % of cancer drug candidates pass clinical trial phase I [143]. 
First of all, one might think of toxic side effects, but non-predictive nature regarding 
bioavailability and that there is a high rate of non-correlation between species is also 
problematic [144]. In a NIH director’s blog entry, current director Collins refers to different 
linkages between human genes addressing sepsis, trauma and burns compared to genes in 
mice. A circumstance which lead to about 150 drugs failed-by-design in humans [145]. Despite 
it is known that human patients may be exposed to severe unknown side effects, animal 
models for clinical research interfere establishing appropriate predictive models [146]. In a 
2015 released article Green enumerates clearly a lot of attributable reasons for both issues: 




thesis had several important advantages. They are easy to culture in vitro. Changes in 
response to flow culture are already observable on a macroscale level through cellular 
alignment. Since directly in contact with the blood flow in vivo ECs are the first cells to 
encounter xenobiotics and to get in contact with immune cells. Thereby they regulate important 
functions of the vascular bed: restrictive barrier [151, 152], immune cell adhesion, migration 
and infiltration [153] of underlying tissues, molecule passage [28, 152] and uptake of drugs 
[154]. A simple mimicry of the vasculature is also important for nutritional renewal in MPS since 
a lot of organ tissue specific cell types do not experience high flow and shear rates within the 
human body and may react very sensitive to it. Yet, diffusion distances for oxygen and nutrients 
are small before totally consumed. A rapid supply without impairing the cells must be ensured. 
4.1 MOTiF biochip design enables innovative in vitro endothelial cell culture
Biochip-based systems are on the verge to revolutionise in vitro cell culture and pre-clinical 
drug testing. A smart design enables the overall control of cellular microenvironments with 
focus on the replication of in vivo like settings to maintain an in vivo like cell phenotype [148]. 
Simple approaches use commercially available two-dimensional perfusion chambers. Despite 
perfusion of cells, more complex biologic processes like cell layer permeability studies, cellular 
transmigration, vertically applied molecular gradients and directed secretion of chemokines 
achieved through cell polarity cannot be studied. Subdividing the perfusion channel by a 
porous membrane horizontally within the MOTiF biochip overcomes these limitations and 
additionally enables basal cellular perfusion (3D perfusion). Furthermore, the free hanging 
membrane is more flexible than rigid surfaces and additionally supports cellular adjustment to 
mechanostimulatory cues transduced by the substrate. Contact angle measurements and 
computational fluid dynamic simulations revealed a laminar flow profile within the MOTiF 
biochip. A laminar flow profile is of high importance for a healthy EC phenotype [50, 155]. It is 
shown that ECs exposed to oscillatory or turbulent flow exhibit a polygonal morphology [156, 
157], increased cellular turnover [40, 95] and that they show different global gene expression 
patterns [158] and higher secretion levels of MCP-1 and IL-8 [159]. In the literature, these 
observations are consistently discussed by linking altered flow profiles with atherosclerosis [6, 
95, 160]. Given the integrated key feature of the porous membrane subdividing the perfusion 
channel, we also perfused EC layers three-dimensionally, i.e. from the apical and basal side 
of the cells. This resulted in a high remodelling of cytoskeleton and exhibited an increased 
cellular height compared to standard flow chambers. Moreover, we observed an increased 
expression of vWf in MOTiF biochips independently form shear stress with highest expression 
in areas of high pore-density. The formation of in vivo-like high molecular weight vWf strings 
[161, 162] was also detectable. A neutral extracellular pH-value influences vWf string formation 
in WPBs [163] and is promoted by the continuous nature of perfused EC culture. Von 
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Willebrand factor exocytosis is furthermore regulated through VEGF-receptor 2 signalling by 
mechanostimulation [164]. Three-dimensional flow conditions might stretch the membrane 
thereby triggering the ECs to release vWf. In vivo these vWf strings remain temporarily 
associated with the cells [165, 166] and contribute to a healthy endothelium [167]. Increased 
cellular heights could also be found in other perfusion models of renal tubular epithelial cells 
[104, 124]. It seems to be a common characteristic of perfused endothelial and epithelial cells. 
But nutritional supply and catabolite removal by only apical perfusion in standard perfusion 
chambers restricts cellular growth and height and does not have such great impact on EC 
phenotype as could be shown with 3D perfusion conditions. Another innovation within the 
MOTiF biochip design relies strictly on the use of the plastic cell culture substrates such as 
COC and PS and the integration of PET membranes. Most similar applications are made of 
PDMS, mainly because soft-lithography based methods for an easy fabrication and rapid 
prototyping are well established [168, 169]. However, this material bears some disadvantages 
for (EC) cell culture (cf. 1.3.2). It should be added, that it absorbs small [101] and hydrophobic 
[109] molecules rendering the material impractical for substance and drug testing. Compared 
to other chip designs, the MOTiF biochip is modular. It is possible to attach a second chip body 
underneath the first modifying the former second level to a membranous structure thereby 
creating a third level for cell culture and perfusion. This was done for the development of a 
BBB-like model (cf. manuscript III) enabling complex 3D cell culture. The new channel height 
of 1.1 mm in the middle of the modular biochip enables the integration of pre-cultured tissue 
spheroids, which were immobilised on a porous membrane containing microcavities of 800 
µm. In general, different cell supporting surfaces can be easily integrated by replacing 
membranes. However, throughout all experiments PET membranes with 8 µm pore diameter 
and a pore density of 105 / cm² were used for EC culture establishment. Taken together, the 
MOTiF biochip design sets up favourable culture conditions for endothelial cells: individual two-
dimensional and 3D perfusion, precise control of shear stress, a membrane as scaffold 
additionally allowing mechanostimulation and a chip bulk material suitable for substance and 
particle testing. 
4.2 Microfluidically perfused endothelial cell layers benefit morphologically and on the 
molecular level 
4.2.1 Improved perfusion conditions support endothelial cell biology
ECs are exposed to various stimulatory cues throughout the vasculature: shear forces, 
different types of flow profiles (laminar, oscillatory or turbulent), mechanostimulatory stretch, 
interaction with perfused cells of the blood and immune system. They all show a strong impact 
on endothelial physiology [10, 11]. As pointed out above, MOTiF biochips are suitable for 
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endothelial perfusion in a 3D fashion. This should lay the foundation for establishing flow 
culture for this thesis and for further research projects. To test, if EC layers within MOTiF 
biochips behave like it is reported in the literature for endothelial flow culture, ECs were 
perfused for 24 h. Different shear stress rates of 0.07 Pa (0.7 dyn / cm²) and 1 Pa 
(10 dyn / cm²) were chosen to characterize cellular adaption to altered environmental 
conditions. Results were additionally compared to standard flow chambers and static culture 
conditions (cf. manuscript I). Initially, improved perfusion conditions resulted in a more viable 
cell layer in MOTiF biochips compared to standard flow chambers. We hypothesize that this 
might be triggered by an improved removal of catabolites and supply with nutrition related to 
bidirectional apical and basal perfusion of ECs. As expected, morphological adaption of cells 
to shear stress and flow have been observed. Cell shape index (CSI) analysis revealed 
significant differences between perfusion in standard flow chambers and MOTiF biochips with 
significant lower values in the latter indicating more stretched and aligned ECs. This was 
accompanied by extensive cytoskeletal remodelling and higher cell densities in the MOTiF 
biochip. This was indicated through prominent F-actin expression and stress fibre formation in 
MOTiF biochips additionally promoting changes in cellular alignment and a decrease in CSI. 
Results obtained for static as well as standard flow chamber experiments differed in CSI and 
F-actin expression intensity and pattern with inferior results. This might be due to chip design 
and the nature of materials chosen as cell culture surface: flexible membrane in MOTiF 
biochips vs. rigid channel surface in standard perfusion channels (cf. 4.1). Additional stretch 
of at least 4 % applied to ECs enhances cellular alignment in flow direction, stretch of at least 
7 % also cellular elongation. Moreover, this correlates positively with prominent F-actin stress 
fibre formation when stretch forces and shear stress increase [170]. Although we can only 
speculate, this type of mechanostimulation might be responsible for a more distinct endothelial 
phenotype with strong F-actin fibres and might result in stronger endothelial attachment since 
cell numbers in MOTiF biochips increase with applied forces. This is in contrast to data from 
standard Boyden chambers, in which EC numbers decrease. The only obvious difference can 
be seen in the surface condition and 3D perfusion. The enhancement of vWf expression 
independently from shear stress can be regarded as further evidence for mechanostimulatory 
cues coming from the flexible membrane surface, again emphasising how the newly developed 
MOTiF biochip supports EC culture (cf. 4.1). Interestingly, ultra large vWf strings seem to be 
important for the initial pathogenic step of S. aureus-induced endocarditis in patients with a 
healthy endothelium [171]. Since the exact mechanisms of vWf string formation still remain to 
be uncovered, endothelial cell culture in MOTiF biochips represents an interesting approach 
to study vWF biology and its interaction with immune cells under flow conditions. 
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4.2.2 Endothelial barrier modulation and immune cell recruitment: recreation of 
inflammatory events within MOTiF biochips
The maintenance and regulation of the endothelial barrier is crucial for endothelial interactions 
with immune cells in health and disease. Among others, EC junctional integrity is regulated by 
PECAM-1 [23]. It was found to be significantly upregulated in MOTiF biochips when EC layers 
were perfused three-dimensionally. This was accompanied by elevated ZO-1 levels under high 
shear stress. ZO-1 also contributes to endothelial barrier formation [3]. Elevated levels of both 
proteins contribute to a tighter endothelial barrier within MOTiF biochips. Moreover, thickened 
endothelial layers mediated by extensive cytoskeletal remodelling enhance barrier formation 
in perfused biochip cell culture. Similar observations were made on renal tubular epithelial cells 
in biochip models of the human kidney [104, 124]. To test barrier functionality and modulation, 
pro-inflammatory cytokines TNF and  were applied basally. It is reported that PECAM-1 
is downregulated and redistributed during inflammatory events [172] leading to an impairment 
of endothelial barrier function [173]. ZO-1 responds to  treatment with decreasing protein 
levels and subcellular localization [174]. Cytokine stimulation of ECs resulted not only in a loss 
of PECAM-1 and ZO-1 protein expression as could be shown by immunofluorescence staining. 
An overall cellular elongation was observable additionally. Stroka et al. were able to show that 
this enhanced elongation observed in TNF treated ECs is accompanied with dynamic shifts in 
cytoskeleton and reduced cell stiffness [175]. Thus, a barrier breakdown and leakage 
visualised by FITC-dextran passage is a combination of decreased protein levels and reduced 
cellular cytoskeletal stiffness. Impaired endothelial barrier function contributes to various 
diseases such as sepsis and associated inflammatory syndromes leading to bacterial 
translocation [30], and it also contributes to injury like trauma and burns [29]. In the context of 
inflammatory processes, we then investigated the expression of cell adhesion molecules on 
perfused EC layers in MOTiF biochips. TNF treatment furthermore activates the endothelium, 
which also includes an altered cell adhesion molecule expression linked to inflammatory 
processes [31, 176, 177]. In MOTiF biochips it was found that ECs exhibit a characteristic cell 
adhesion molecule expression profile in response to shear stress. In agreement with data from 
previous work ECs adapt to high shear stress rates by upregulation of ICAM-1 and VCAM-1 
[51, 178]. Upon TNF treatment ECs showed decreased levels of ICAM-1, VCAM-1 and E-
selectin under shear stress when compared to static cell culture. Laminar shear stress 
attenuates the expression of VCAM-1 and E-selectin after TNF treatment by  signalling 
pathways [179, 180] as well as does flow-mediated release of nitric oxide [181]. However, in 
these studies ICAM-1 upregulation was shown in response to TNF treatment within flow 
conditions. This might be due to different stimulation times used in all these studies [179, 180]. 
Stressing that point again, endothelial layers within MOTiF biochips are exposed to low 
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stretching due to membrane flexibility, it is possible that this mechanostimulation contributes 
to the observed reduction of ICAM-1 expression. In another study TNF treated ECs show 
diminished ICAM-1, VCAM-1 and E-selectin expression when exposed to 1.5 Pa shear stress 
and 100 mmHg hydrostatic pressure [182], which is in accordance to the results obtained in 
our study. Altered CAM expression could be further successfully tested for functional relevance 
regarding immune cell adhesion under perfusion conditions. The application of shear stress 
revealed significantly less immune cell adhesion on ECs without TNF treatment compared to 
static condition. But there was still a decrease in THP-1 adhesion with increasing shear stress 
observable which was in accordance with the observed CAM expression profile after 24 h. The 
first of the three basic steps in cell adhesion involves selectin-mediated rolling along the 
endothelium, the second is characterized by integrin activation and the third involves integrin 
mediated adhesion to CAMs [17, 183, 184]. The balance between these adhesive forces and 
additionally applied dispersive hydrodynamic forces determines cell adhesion [185]. In vivo 
diminished expression of these molecules in response to flow might help keeping the balance 
in a healthy state, even during inflammatory processes, preventing massive immune cell 
recruitment and detrimental immune cell activation. Flow-mediated cell adhesion is not only 
crucial for immune cell recruitment and migration. The concept of flow mediated distribution of 
cells and subsequent adherence at particularly exposed sites of the vasculature is highly 
important in cancer cell metastasis. Tumour cell-endothelial and tumour cell-matrix interactions 
determine their metastatic potential [184]. A multifactorial analysis is of high importance since 
not only receptor-ligand interactions influence cell adhesion but different kinds of shear stress 
at different sites throughout the vasculature also strongly contribute as could be demonstrated. 
Hence, improved perfused EC cultures in MOTiF biochips could contribute to studies of 
vascular inflammation and vascular tumour cell interaction.  
EC biology relies strongly on culture methods chosen as could be shown in manuscript I. 
Cellular growth regarding cell densities, cellular heights, cellular shape and alignment as well 
as molecular configuration strongly depends on applied shear forces and perfusion regime. 
These shear forces simulate in vivo-like conditions helping to create target-oriented 
microenvironments of different kinds of vascular beds. Even the nature of applied forces (two-
dimensional vs. 3D perfusion; rigid vs. flexible substrate surfaces) results in strong differences 
and reveals cues about the importance of multifactorial cell culture techniques. Functional 
effects can be seen on the molecular level with different expression patterns for endothelial 
marker proteins, adherens and tight junction molecules corresponding to barrier functionality, 
CAMs and related cellular interactions and recruitment. Hence, EC layers benefit 
morphologically and on the molecular level when cultured under flow conditions. These 
perfused EC layers could further improve studies on vascular inflammation, EC barrier 
modulation and tumour cell adhesion.
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4.3 Distinct microenvironmental modulation mediates endothelial-nanoparticle 
interaction
4.3.1 Mechanomodulatory cues influence endothelial cell nanoparticle uptake 
Microenvironmental conditions influenced by non-biological – at least in context of ex vivo 
culturing – factors such as shear stress and mechanostimulation as well as culture surface 
materials and geometric design of novel culture devices have strong impact on EC outcome. 
Distinctive results of shear stress influence on endothelial culture (cf. manuscript I) lead to a 
follow up study on NP uptake under different shear forces and with different polymer 
compositions (cf. manuscript II) as part of this thesis. Based on the shear stress-mediated 
alterations in endothelial biology on morphological and molecular levels, we hypothesised a 
strong impact in a pharmaceutical screening context. ECs are the first cells throughout the 
circulation to encounter xenobiotics. Furthermore, polymer-based NP drug delivery gets more 
into research focus due to improved pharmacological properties, higher efficacies and reduced 
side effects compared to direct drug application [64]. Nanoparticle uptake is affected by size, 
shape, surface charge and protein corona [67, 74]. These factors influence and challenge 
biodistribution and determine the interaction with the RES. Further, predictions concerning 
uptake and clearance remain challenging tasks, especially when translating in vitro data into 
in vivo research [186, 187]. These concerns were addressed by investigating the uptake 
behaviour of a well-designed NP library with different characteristics under a range of shear 
forces in perfused EC culture. Initially, NP composition and applied shear stress were of 
interest, that’s why a simple standard flow culture design was chosen to not elaborate study 
design too much. First, NPs consisting of different compositions of 3 % PMAA and 13 % PMAA 
or 20 % PDMAEMA were characterised in size, shape and charge by colleagues before 
subjecting them to flow-based uptake studies on ECs. Batches of 200 nm in particle size were 
selected where endocytosis could be assumed as internalisation mechanism. Four different 
kind of shear stresses were chosen: 0.07 Pa (0.7 dyn / cm²) representing basal medium 
exchange with low stimulating effects on endothelial biology and is assumed to be present in 
the human hepatic sinusoid, 0.3 Pa (3 dyn / cm²) and 0.6 Pa (6 dyn / cm²) in human veins and 
venules [6], the latter one also in human suprarenal aorta and 1 Pa (10 dyn / cm²) representing 
conditions to be found in human common carotid artery [116]. Our initial hypothesis would have 
expected to reveal a decreasing NP uptake with increasing shear forces. Keeping experimental 
parameters defining shear stress steady, such as medium viscosity and channel properties, 
higher shear forces are only obtained by an increase in flow rate (cf. eq.1, 1.3.3). We 
hypothesised a shorter interaction time between particles and cells would lead to an impaired 
uptake rate. All three NP compositions falsified this assumption by showing a positive 
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correlation between increasing shear stress and the total amount of internalised NPs. These 
results indicate a strong interaction, adhesion and internalisation with ECs even at high shear 
forces for the chosen type of particles. On the one hand, endothelial uptake is positively 
modulated by high shear forces. Endothelial permeability for macromolecules such as LDL 
increases [41] and most likely may an altered endocytosis profile influence NP uptake. On the 
other hand, the observed uptake profile might be a NP material-dependent observation. A 
review of the literature supports the initial assumptions since other studies investigating SiO2-
NPs or PS-based NPs showed reduced uptake rates under increasing shear stress conditions, 
even in the presence of targeting antibodies [154, 188, 189]. These findings suggest enough 
cell-target interaction in vivo for the methacrylate-based particle compositions. But uptake 
rates differed markedly among the particles from our library. Compared to static conditions a 
higher frequency of particle-cell interaction with increasing flow rates facilitated particle uptake 
with lowest uptake rates for 3 % PMAA and highest uptake rates for 20 % PDMAEMA in 
general. Interestingly, with the highest shear stress of 1 Pa endothelial-particle interaction 
changed and 20 % PDMAEMA particles showed less uptake efficiency than 13 % PMAA which 
stands in contrast to static and low shear stress observations. These effects might be most 
likely evoked by different surface protein expression patterns and EC responses to shear 
forces as the results from manuscript I suggest (cf. 4.2). As a conclusion shear forces applied 
in perfused EC layers emerge to be key features influencing NP uptake and represent an 
important screening characteristic. Differences between static and dynamic culture conditions 
emphasise these assumptions. Most importantly, in comparison to the literature, perfused EC 
layers might reveal unique EC-NP interactions (elevated or reduced) that are not visible in 
static culture.
4.3.2 Tissue-resident macrophages dampen endothelial nanoparticle uptake rates
It was important not just to reflect conditions present along the vasculature, but also to address 
liver sinusoidal physiology with emphasis to shear forces and phagocyting cells. The liver plays 
an important role in drug and NP clearance metabolizing 73 % of the most common drugs 
[190]. Most responsible for this clearance capacity is the cytochrome P450 enzyme group [191] 
and tissue resident macrophages known as Kupffer cells, respectively. These cells line the 
walls of the liver sinusoid, reside within its lumen among ECs and are as well highly 
programmed to phagocyte particles from the blood stream [192, 193]. Moreover, cell-cell 
interactions, especially between different type of cells, have strong impact on cellular 
behaviour. Thus, in a second step macrophages were introduced into endothelial chip culture 
for studying NP fate upon perfusion with respect to physiologic implications in a heterogeneous 
cell environment. Also, in the presence of macrophages, a shear stress dependent increased 




experiments mediates endothelial behaviour towards in vivo-like settings.
4.4 Perfused endothelial cell layers contribute to the design of complex 
microphysiologic systems
MOTiF biochip models incorporating multiple cellular growth and perfusion dimensions, bare 
the possibility to emerge as promising tools to recapitulate diverse biologic processes like 
cellular growth, ADME processes of particles and substances as well as cellular cross-
communication. A free hanging membrane further subdividing culture cavities in separate but 
interacting compartments thereby providing scaffolding surfaces, facilitates these new 
advantages. These settings provide the technical setting to build up organ-like structures and 
mimic organ-like functions on a microscale: the concept of MPS [96, 196]. 
4.4.1 MOTiF biochips support the culture of various endothelial cell types and enable 
molecular cross-talk between compartments
In MOTiF biochips, characterised EC layers may serve well as a simplified structure mimicking 
the vascular bed under perfusion conditions. ECs of various origins can be easily cultivated in 
MOTiF biochips and adapted to microenvironmental cues such as shear stress. Cell cultures 
opposite of the membrane can be designed in an organotypic microanatomy by mixing up or 
layering cell types in appropriate arrangements. We used this approach to create a BBB-like 
MPS combining the hCMEC/D3 cell line with murine cortical spheroids derived from embryonic 
stem cells (cf. manuscript III). The MOTiF biochip design was improved by introduction of a 
lower shell attached to the upper basic part via adhesive films. The integration of a second 
membrane beneath the original membrane of the upper part divided the chip into three 
microchannels with each bearing the option for cell culture and perfusion. The newly introduced 
membrane comprises thermo-formed micro-cavities with a diameter of 800 µm and pores with 
a diameter of 5 µm and allows the immobilization of cortical spheroids. Flow-induced shear 
stress substantially benefits to microvascular endothelial morphology, tight junction formation, 
receptor and transporter protein expression resulting in an improved BBB tightness and 
functionality [85]. Up to date, most published in vitro models of the BBB use static cell culture 
approaches [197], commonly in a transwell-design [198, 199]. The transwell assay has proven 
to be useful studying transport processes across tissue barriers [200], but was so far not 
perfusable. Thus, microfluidic chip-based solutions were developed. Herland et al. co-cultured 
human brain microvascular ECs (hBMECs) with pericytes and astrocytes in a semi-perfused 
approach. Their model did not undergo a microfluidic priming and adaption as cells were 
perfused only for some hours for analytical purposes. In this model, the BBB was responsive 
to stimulation with TNF as indicated by the release of G-CSF and IL-6 into the culture medium 
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[103]. Besides that, only a few studies have been reported to be microfluidic-based [201], 
thereby mimicking physiological shear stress conditions. One of the earliest models was the 
µBBB published by Booth and Kim [105]. Like most BBB models [202, 203], cells of rodent 
origin were used. Murine CMECs were co-cultured under perfusion with astrocytes which they 
reported to result in a significant increase in transendothelial electrical resistance (TEER) 
values. Similar observations were made in the Sym-BBB model of Prabhakarpandian and 
colleagues. Astrocyte- conditioned medium and shear stress resulted in an increased tight 
junction expression and decreased permeability of the endothelial layer [202]. Recently, more 
complex models included pericytes [203, 204]. In a novel microfluidic bioreactor, Brown et al. 
recreated the setting of a neuro-vascular unit by co-culturing ECs, astrocytes, pericytes and 
neurons. They tried to provide a micro-environment that favours the paracrine signalling 
between the cell types needed for the long-term stable differentiation of the BBB [204]. 
Subsequent analysis revealed substantial improvements in barrier formation regarding 
increasing TEER values, increasing protein expression of -Catenin, decreasing permeability 
[203] as well as increasing tight junction formation [203, 204]. For a first approach, we chose 
the hCMEC/D3 cell line, which is reported to form a physiological barrier already in the absence 
of glia cells, astrocytes or pericytes [205, 206]. However, we additionally integrated complex 
neural tissue cultures. In our model, we demonstrate that our biochip-based approach allows 
the co-culture of endothelial hCMEC/D3 cell layers and cortical tissue spheroids under 
physiological perfusion conditions. Endothelial hCMEC/D3 layers still expressed central 
marker proteins known to regulate BBB integrity and flexibility in vivo such as vWf, VE-
Cadherin, ZO-1 and  [207-212].  Neural differentiation markers Tbr1, Tbr2 and Pax6 
representing regulators of neocortical development [213-218] did not show significant 
differences in their expression levels when spheroids were cultured in the biochip setting.
Additionally, we performed functional testing under inflammatory conditions. It is crucial to 
combine an endothelial barrier with neural tissue in respect to the investigation of neuro-
inflammatory processes and how both cellular environments affect each other. In this context, 
most microfluidic based BBB models are also designed in a PDMS chip environment. This 
enables highest flexibility for researchers in study but bears important disadvantages in 
experiment quality (cf. 1.3.2). Most importantly it adsorbs small and hydrophobic molecules 
rendering a BBB-like cellular environment impractical for substance and drug testing. However, 
barrier regulation and modulation by agents as well as substance passage are the most 
important issues in BBB models. We specifically can reproduce cytokine induced cellular 
damage such as the disruption of the endothelial barrier function with a nearly tenfold increase 
in 3 kDa FITC-Dextran leakage accompanied by subsequent alterations in neural cell 
morphology, increased neural cell death, diminished spheroid tissue integrity and decreased 
expression of neocortical developmental markers. These observations are in agreement with 
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findings from studies in other microfluidically perfused BBB models focusing on barrier integrity 
and modulation [210, 219] as well as studies made in mice regarding neocortical development 
under inflammatory conditions [220-222]. The data thus show that the presented in vitro model 
comprising an endothelial hCMEC/D3 barrier and cortical tissue spheroids can reflect crucial 
aspects of neuroinflammation during neocortex formation. This model however bears certain 
limitations. Of particular importance is the absence of astrocytes and pericytes. Both cell types 
are reported to improve microvascular endothelial barrier functionality [202-204] via 
paracellular signalling [223]. Moreover, resembling the setting of a neurovascular unit with 
endothelial, glia and neural components as well as basal lamina and ECM embedding is more 
favourable because of diverse interactions as well as the comprehensive impact of BBB 
modulation on neural tissue and vice versa. Such an approach would reflect the highly complex 
setup to be found at the neurovascular unit more physiologically [224]. This would render the 
system more predictable in relation to inflammatory condition modelling as well as for studies 
of drug applications regarding BBB passage and uptake capabilities at neural target sites. 
However, the current approach was chosen to have a first proof-of-principle with a simple 
cellular setup and a sustainable co-culture of different cell types and of different origins in the 
biochip. Follow-up studies will focus on an inclusion of astrocytes and/or pericytes as well as 
neurons or neural tissue of human origin to improve this first approach. Moreover, our biochip-
based system currently lacks the ability to directly measure TEER values generated by the EC 
layers as electrodes between the cortical tissue spheroids and microvascular EC layer may 
affect spheroid growth as well as spheroid introduction into the biochip. Another point is the 
relatively large distance of 0.7 mm and the resulting volume of 160 µl between the co-cultured 
cells. This might influence endocrine and paracrine signalling between microvascular ECs and 
the neural tissue. Relatively large distances between neural tissue and microvascular ECs 
could be overcome by embedding interneurons and astrocytes in an ECM-like collagen gel to 
close the rather wide gap. However, to the best of our knowledge we reported for the first time 
a biochip-based model supporting the co-culture of a cerebral microvascular endothelial barrier 
and cortical tissue spheroids. The model resembles physiological shear stress conditions and 
allows a direct assessment of neuroinflammatory effects on vascular and neural tissue 
components. In conclusion, this model represents a valuable tool of the cerebral vascular 
crosstalk for suitable for further applications. It bears the option to study microvascular 
endothelial barrier integrity under the influence of drug or drug carrier administration (cf. 
manuscript IV and 4.4.2). Further, tissue integrity during as well as molecular mechanisms of 
diseases such as ischemia, trauma, brain tumours and brain infections could be investigated 
with further development of the model. Additionally, the results from manuscript III underline 




4.4.2 Microphysiologic endothelial tissue barriers support in vitro drug screening
Microvascular endothelial barrier integrity plays an important role in drug administration and 
displays one of the most challenging obstacles regarding drug and nucleic acid delivery in the 
pharmaceutical industry [27]. The BBB is highly selective and passage of small molecules is 
strictly regulated [21] in a bi-directional way through several transport mechanisms [28, 225]. 
The functionalisation of nanocarriers with target moieties displays a key strategy to benefit 
from the active transport system to transport larger molecules. In this context, GSH-modified 
nanocarriers have been designed to demonstrate a facilitated transport of nucleic acids for 
therapeutic gene delivery across the BBB (cf. manuscript IV). Glutathione has already been 
reported to successfully cross the BBB in in vivo rat models and in vitro transwell assays [226, 
227] as well as being used as NP coating agent [228-231]. The polyplex nanocarriers tested 
in this study have been investigated under physiological shear stress conditions of 0.4 Pa 
within a simplified human model of the BBB biochip system. We could already show that 
dynamic cell culture and shear stress has a profound impact on EC-NP interaction 
(cf. manuscript II and section 4.3) We could demonstrate the feasibility of microfluidically 
perfused endothelial layers to evaluate EC-NP interaction also for testing of peptide-decorated 
nanocarriers. Similar to results obtained in the study “Comparison of the uptake of 
methacrylate-based nanoparticles in static and dynamic in vitro systems as well as in vivo” 
(cf. manuscript II), it was shown that perfusion has a profound impact on nanoparticle uptake. 
In static control experiments (cf. suppl. information manuscript IV), two polyplex candidates 
showed superior interaction with microvascular hCMEC/D3 cells over the third candidate which 
was eventually evaluated to be best suited for transendothelial passage in perfusion 
experiments. Further, sustained endothelial barrier integrity for the lead candidate was 
demonstrated by immunofluorescence staining of tight and adherence junction proteins. Both 
approaches verified the favourable characteristics of diminished EC-NP interaction and 
increased barrier passage while preserving barrier integrity. With this study, we further showed 
the suitability of the MOTiF biochip for basic research as well as for nanocarrier screening 
purposes regarding uptake, trans-endothelial passage and toxic effects. One of the earliest 
microfluidic chip-based BBB models, the µBBB model [105], was used to study permeability of 
FITC-Dextran of different sizes in an murine EC and astrocyte co-culture approach to show 
the models suitability for drug delivery studies to some extent.  This was further proven by a 
follow-up study using seven known neuroactive drugs including Ethosuximide (antiseizure 
medication) and Sertraline (antidepressant) for trans-endothelial passage [232]. 
Prabharkapandian et al. exemplarily demonstrated the application of the rat EC based sym-
BBB model in an efflux study with rhodamine 123 and known L-type calcium channel blocker 
Verapamil to inhibit P-glycoprotein efflux transporter [202]. Brown et al. demonstrated the 
feasibility for such models by investigating the active trans-endothelial transport of ascorbate 
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across human brain microvascular ECs [204]. Most of the established models so far use cells 
of animal origin and neither of them has been used to study nanocarrier interaction at the BBB 
or nanocarrier transendothelial passage. This might be due to the early stage of the field of 
microfluidic in vitro BBB models concomitant with limitations taken into account as has been 
reviewed by Åberg [233]. To date, NP studies considering microenvironmental cues including 
shear stress and blood flow characteristics have been performed in vivo (comprehensively 
reviewed in [234]). Here, we report for the first time a novel nanocarrier with GSH moieties to 
cross the BBB which was designed for gene delivery within a microfluidic biochip-based model 
with microvascular ECs forming a BBB surrogate. In vivo models are suitable to finally examine 
nanocarrier distribution throughout the whole body as well as nanocarrier metabolism and 
excretion which cannot be achieved yet by MPS [199]. However, animal models on the other 
hand are very expensive, need a high level of expertise in handling and are time consuming 
to operate [199]. Thus, perfused endothelial layers from various sites of the vasculature or in 
particular MPS of the BBB represent valuable tools to preselect carrier design and polymer 
formulations regarding tissue target sites, cellular interaction, transendothelial passage 
capabilities and cytotoxicity on human cells in a more physiologic cellular microenvironment. 
Now, microfluidic chip-based models just evolve to substantially replace animal testing 
eventually some day in the future with still a lot of effort to put in for refinement and further 
development. However, with the investigation of perfused endothelial cell layers recreating 
microphysiological conditions of the vasculature, we could demonstrate that they are on their 
way to already complete scientific tools for improved recapitulation of EC biology 
(cf. manuscript I), to study influences of cellular crosstalk (cf. manuscript II), to establish more 
sophisticated MPS (cf. manuscript III) and for improved screenings under physiologically more 
relevant conditions (cf. manuscripts II and IV). On the long-term they might bare the ability to 
close interspecies data transferability gaps.
4.5 Further developmental potential regarding the improvement of endothelial and 
vascular in vitro research
The thesis shows the implication of a microfluidically perfused biochip for endothelial vascular 
layers in mono-cell culture and several co-culture strategies with tissue-resident macrophages 
or adjacent neural tissue. Further, its additional value for PMAA-based NP and GSH-coupled 
nanocarrier screening could be successfully demonstrated. The selection of a defined 
microenvironment, especially the inclusion of shear stress but also of other cell types, has a 
strong impact on endothelial outcome and performance within uptake studies. The biochip 
approach itself and the concept of a membrane as cell culture scaffold within the biochip 
thereby creating two single perfusable channels comprise a high potential for further 
developmental effort (I) to improve the system on a technical and (II) cellular basis as well as 
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(III) to integrate endothelial / vascular cell layers into other MPS.
4.5.1 Technical improvement strategies for perfused vascular endothelial cell culture
4.5.1.1 Quantification of endothelial barrier integrity
Endothelial barrier integrity plays an important role in maintaining vascular homeostasis. ECs 
form a restrictive barrier to regulate tissue fluid homeostasis, nutritional supply of adjacent 
tissue and immune cell infiltration / transmigration [151, 152] (cf. 1.1.2). Endothelial barrier 
integrity can be evaluated easily by fluorescence-labelled molecule diffusion, i.e. FITC-
Dextran, but also by TEER measurement providing an even more precise readout for 
assessment of barrier integrity. Leaky cell layers with gaps are less detectable by simple 
molecule diffusion than by electrical resistance measurement. Substantial increase in TEER 
can be monitored already on a molecular level in a confluent EC layer when tight junctions 
start to form and begin to close intercellular space. TEER values depend also on endothelial 
localization within the vascular bed, thus being heavily influenced by endothelial function. 
HUVECs display TEER values between 6-20  . cm² [235, 236] whereas hCMEC/D3 are able 
to generate TEER values up to 1200  . cm² under pulsatile perfusion which is in accordance 
with data on microvascular ECs obtained in vivo [206]. Thus, the biochip-based EC culture 
approach presented in this thesis would benefit from the integration of electrodes to measure 
TEER values. One possible implementation without extensive redesign of the biochip body 
would be using conductive materials for the biochip bonding. Indium tin oxide (ITO) is a 
promising candidate as it assures electrical conductivity to external electrodes while being 
transparent for monitoring cell culture in the biochip or performing live cell imaging under 
perfusion conditions [237]. First experiments have already been conducted.
4.5.1.2 Modulating flow profiles and membrane flexibility
Flow profiles are of major importance regarding EC culture under physiological aspects in vitro. 
Detailed data presented in this thesis on apical and basal perfusion as well as on applying 
different shear stress rates to EC layers emphasise the impact on cellular morphology and 
performance. Laminar or laminar pulsatile shear stress is related to the development of a 
healthy endothelial phenotype [39, 41]. In contrast, oscillatory or turbulent flow are linked to 
atherosclerotic processes in the vascular bed [6, 95, 160]. Besides laminar flow, ECs are 
among the cell types with the strongest exposure to mechanical stretching [57]. Cellular 
stretching improves ECs on a molecular and functional level [164, 170]. Moreover, 
mechanostimulative stretch positively influences SMC outcome of the vascular bed including 
cell orientation, phenotype and functionality [133]. Thus, developing pulsatile flow profiles by 
precisely regulating alternating flow with short increases in velocity would benefit to induce 
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slight membranal stretching. Further the inclusion of more flexible membranes would benefit 
the EC and overall vascular biology. Hydrogel-based membranes [238, 239], bioinspired 
polymer membranes [240] or cellulose-based constructs [241] could be applied. Stretch as 
well as changes in hydrostatic pressure help to approximate the in vivo micro-environment of 
the vascular bed more precisely. Further, both would contribute to study lung and gut vascular 
cell biology more accurately as tissue stretch and relaxation are immanent characteristics.
4.5.1.3 Online monitoring of physiologic parameters
Non-invasive / non-destructive real-time assessment of cellular parameters is one benefit of 
microfluidic biochip-based cell culture compared to animal experimentation. Devices needed 
for monitoring have less impact on in vitro cell cultures than on whole organisms where altered 
behaviour and high stress levels are most likely to influence measurements. Live cell imaging 
is a method which is already practicable without further adjustments to the biochip. This 
enables real-time monitoring of cellular interaction, adhesion and transmigration processes. 
Introducing TEER measurements to the biochip represents only one possibility for further 
technological development regarding online monitoring. Integration of chemiluminescent 
sensor spots into biochip channels enable the real-time measurement of parameters like pH, 
pO2 or glucose consumption. Techniques to successfully apply sensitive sensor films to 
synthetic foils have already been established [242] and can be routinely integrated into 
microfluidic chips and be readout by colour CCD-camera technology [243]. Lab members have 
already demonstrated the feasibility in monitoring pO2 during microfluidic perfusion culture 
[120]. Establishing sensor spots based on pH measurement within the MOTiF biochip would 
be most beneficial for controlling endothelial phenotype. A neutral extracellular pH-value 
influences vWf string formation [163] observed in healthy endothelium in vivo [161, 162]. 
Monitoring glucose consumption would improve medium exchange protocols as well as it 
would give insight in basic cellular metabolism during studies.
4.5.1.4 Introducing surface modifications
ECs further rely on strong surface adhesion and proper formation of a confluent cell layer to 
withstand shear stress and mechanical forces in in vitro microfluidic biochip cell culture. 
Surface modifications represent possible strategies to facilitate endothelial adhesion and 
growth. Oxygen plasma treatment for surface hydrophilization is routinely implemented into 
the final fabrication steps of the MOTiF biochip. Shen et al. demonstrated that hydrophilic 
surfaces could enhance the expression of focal adhesion protein associated with EC adhesion 
[244]. Furthermore, surface treatment with natural ECM-derived coating agents like collagen I 
or IV, fibronectin and poly-L-lysine has already been implemented into cell seeding protocols. 
With regard to the biochip body itself, surface patterning is one elaborate technique not only 
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to support endothelial adhesion and growth but also to facilitate physiologic alignment 
processes. Hu et al. demonstrated good EC adhesion and superior cellular alignment when 
seeding and culturing ECs on micro-wavy patterns [245]. Oligopeptide surface patterning 
comprising of a motif of arginine-alanine-aspartate-serine (RADS) important for native cell 
adhesion recognition has also been applied successfully to support cellular adhesion and 
defined alignment [246]. Hatano et al. have focused on generating wrinkled micro- and nano-
topographical surfaces to mimic topographical structures of ECM components for guided EC 
culture [247]. Thus, approaches for surface pattering would be most beneficial for microfluidic 
EC culture, especially for studies and applications under high shear stress.
4.5.2. Cellular improvement strategies for microfluidic vascular endothelial cell culture 
4.5.2.1 Integration of key vascular cell types
ECs line the inner surface of the vascular bed[2], yet, ECs in mono-cell culture represent only 
a simplified approach to set up a vascular layer within MPS applications. The vasculature 
consists at least of ECs supported by ECM components and, depending on the site of the 
vascular bed, additionally SMCs, pericytes and fibroblasts arranged in several layers [248]. As 
it could be demonstrated in this thesis, the co-culture with tissue-resident macrophages as 
immune-modulating components further influences shear stress dependent uptake behaviour 
of NPs through ECs. Endothelial-macrophage co-culture further helps to refine vascular cell 
culture and MPS as it enables the study of inflammation dependent processes and tissue 
responses and has been successfully applied in infection models [249, 250]. Endothelial 
monocyte recruitment and tissue macrophage co-culture has also become apparent regarding 
inflammatory processes of the vasculature itself like it is observed in atherosclerotic events 
[251, 252]. Embedding macrophages and recruiting monocytes in microfluidic models has 
further been used to demonstrate macrophage polarization state-dependent control over 
tumour cell line MCF-7 by applying chondramide A as tumour cell cytotoxic agent and actin-
targeting compound [253]. 
Smooth muscle cells act as main constitutor of the media in large blood vessels and are located 
underneath the endothelium. They are in direct interaction with ECs through either immediate 
contact or the release of mediators into the surrounding tissue and medium [254]. EC-SMC 
interaction key regulates crucial processes of the vasculature like vascular tone, SMC 
differentiation, SMC recruitment and influences cellular viability [254], SMC morphology [255, 
256] and orientation [257], SMC collagen synthesis [135] and gene regulation in both cell types 
[258]. Although not in direct contact to the medium (blood), SMCs are also exposed to cyclic 
stretch and shear forces [259]. Importantly, EC-SMC signalling results in atheroprotective 
communication via miRNAs between both cell types [260, 261], key processes which should 
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be considered in developing MPS to investigate inflammatory events. Cellular compositions 
vary depending on the site of the vascular bed. Barrier functionality is critically regulated by 
ECs, but depends also on other co-cultured cell types like pericytes which cover between 10 % 
and 50 % of the endothelial abluminal side and substitute partially SMCs [262]. Within brain 
micro-vessels, pericytes have their highest distribution in total absence of SMCs and ECs are 
in close contact to them [262]. Pericytes play important roles in tightening microvascular EC 
layers [263, 264] also together with astrocytes [223]. These synergistic processes of co-culture 
and microfluidic shear stress application are thus important for further vascular tissue designs 
within MPS and should be carefully considered.
4.5.2.2 Implementing induced pluripotent stem cells and addressing personalised medicine
Not only the consideration and inclusion of specific cell types to recreate the vascular tissue in 
MPS more precisely, but also the origin of cell types is an important factor. Microphysiological 
systems emerge as research and screening tools. Compared to animal studies, these systems 
bare the possibility of faster and partially cheaper research studies with a broader range of 
technical variability [126]. This will become even more obvious when implementing induced 
pluripotent stem cells (IPSCs), a field just emerging in MPS design and application. Induced 
pluripotent stem cells have the advantage of being nearly indefinitely available and they can 
be differentiated into nearly every cell type of the human body [265]. Protocols to generate 
ECs and pericytes [266], vascular SMCs [267] and fibroblasts [268] have already been 
established. Even endothelial subsets considering endothelial heterogeneity have been 
established to differentiate from iPSC via the application of different amounts of VEGF [269, 
270]. Hence, vascular tissue constructs can be generated from cells with a uniform genetic 
background excluding study bias. Further, iPSCs can be generated with moderate effort from 
various cell types and any person thereby lowering the costs to investigate rare diseases or 
enabling personalised medicine.
4.5.2.3 Extracellular matrix, cell polarity and adaptation of in vivo cell arrangements
Cellular arrangement plays an important role when mixing different cell types in co-culture 
approaches. For proper cellular function, they depend on cell-cell contact formation thereby 
regulating overall tissue maintenance and function [271], polarity formation [272] and in 
particular epithelial-endothelial barrier functionality [273]. Furthermore, polarity establishment 
also depends on molecular gradients and the application of certain amounts of anisotropic 
strain on cells [274]. In the human body tissues of all kinds are composed of different cell types 
arranged in a layer like fashion [214, 248, 275-279]. Components of the ECM provide crucial 
environmental cues for cellular organisation [280, 281] and polarisation [282]. Thus, further 
development of vascular endothelial structures in MPS should strongly consider layering 
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different vascular cell types in an organo- / tissue- typic approach including the incorporation 
of ECM components by extrinsic or intrinsic means. When layering different cell types for 
vascular tissue generation such as fibroblasts, SMCs or ECs, simultaneous or successive 
application of ECM components such as collagens, laminins and fibronectins is feasible. 
Moreover, shown by studies of De Clerck et al. from the early 1980s, ascorbic acid can be 
applied during cell layer formation and cell culture to intrinsically stimulate ECM production in 
SMCs as well as ECs [283]. Cell sheet generation and ECM dependent cell sheet stabilisation 
has been successfully applied by using thermoresponsive polymer technology for tissue 
engineering [284-287]. The concept of layered cells has also already been predominantly 
applied in more complex microfluidic cell co-cultures [102, 257, 259, 288, 289]. Although early 
experiments for this thesis using thermoresponsive polymer surfaces for cell sheet layering 
with subsequent transfer into a former version of the MOTiF biochip were rather unsatisfactory, 
abstraction of in vivo-like concepts for the development of endothelial biochip culture to 
vascular biochip culture using cell layering techniques seems to be the most favourable 
approach to generate complex 3D microenvironments. These microenvironments are in turn 
able to self-organise, to differentiate and to structure endothelial-epithelial cell culture [110].
4.5.3. Implementation of vascular endothelial cell layers into microfluidic tissue models 
and microphysiological systems
EC culture benefits from microfluidically perfused culture as could be demonstrated in this 
thesis. Further, in discussing developmental potential of MOTiF biochip approaches, layered 
vascular tissue may represent a future key feature for more complex 3D MPS emulating tissue 
and organ functions. Vascular tissue procures and regulates complex functions like barrier 
integrity, immune cell recruitment, nourishment of and establishing gradients in adjacent 
tissues. Endothelial layers mimicking a vascular bed have been integrated into a variety of 
microfluidic applications of the liver [289], lung [102], in tumour models [253, 290], in models 
of angiogenesis [106] or the blood-brain barrier [204, 232]. Some of the aforementioned 
microfluidic models have already been used to study inflammation and immune cell recruitment 
in the context of sepsis and liver functionality [289] as well as macrophage polarisation state-
dependent tumour cell decay [253, 290]. The integration of vascular components into MPS 
becomes necessary when thinking about the usage of MPS for disease modelling and 
comprehension. This is imminent with recapitulating atherosclerotic processes [157, 291] or 
break down of inflammation-dependent endothelial-epithelial barriers of gut [292, 293] and lung 
[293, 294]. Disease modelling for mechanistic studies in basic research and pharmaceutical 
drug development through the industry is a major point and focus in MPS development. 
Furthermore, there is the near goal to develop microfluidic biochip-based multi-organ 
applications establishing axes of gut – liver, liver – brain or lung – brain to study systemic 
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processes. There is also the great vision to create a “human- / body-on-a-chip” in its very basic 
functions [295, 296]. In this context, implementing vascular endothelial layers into more 
complex and more sophisticated models becomes necessary as it will serve as an 
interconnecting structure and an individual organ-like unit similar to the vascular bed of the 
human body [297]. Based on the concept of mimicking in vivo microenvironments it seems 
more reasonable than solely to rely on artificial channel and/ or tubing structure. Additionally, 
vascularisation of channel and tubing structures might help to establish more physiologic 
surface-to-volume ratios [295]. Regarding organ-targeted nanocarrier uptake studies it is 
crucial to estimate the role of the vascular circulation system with reference to aspects of 
unfavoured uptake and inflammation-associated endothelial and macrophage activation. 
Endothelial heterogeneity will gain more importance in complex devices as well to fully 
comprehend in vitro targeted vascular or microvascular barrier permeation under in vivo-like 
parameters. The underlying concept of organoid design was performed within other follow-up 
studies of our group [120, 253, 289, 290]. The initial characterization of endothelial layers within 
biochips and its application (cf. manuscripts I and II, cf. 4.2 and 4.3) and the further gained 
knowledge from this thesis served well in further study designs and will help to implement 




1. Sumpio, B.E., J.T. Riley, and A. Dardik, Cells in focus: endothelial cell. Int J 
Biochem Cell Biol, 2002. 34(12): p. 1508-12.
2. Davies, M.G. and P.O. Hagen, The vascular endothelium. A new horizon. Ann 
Surg, 1993. 218(5): p. 593-609.
3. Schnittler, H.J., Structural and functional aspects of intercellular junctions in 
vascular endothelium. Basic Res Cardiol, 1998. 93 Suppl 3: p. 30-9.
4. Aird, W.C., Phenotypic heterogeneity of the endothelium: I. Structure, function, 
and mechanisms. Circ Res, 2007. 100(2): p. 158-73.
5. Ballermann, B.J., et al., Shear stress and the endothelium. Kidney Int Suppl, 
1998. 67: p. S100-8.
6. Malek, A.M., S.L. Alper, and S. Izumo, Hemodynamic shear stress and its role 
in atherosclerosis. JAMA, 1999. 282(21): p. 2035-42.
7. Ku, D.N., et al., Pulsatile flow and atherosclerosis in the human carotid 
bifurcation. Positive correlation between plaque location and low oscillating 
shear stress. Arteriosclerosis, 1985. 5(3): p. 293-302.
8. Bhagat, K., Endothelial function and myocardial infarction. Cardiovasc Res, 
1998. 39(2): p. 312-7.
9. Pearson, J.D., Normal endothelial cell function. Lupus, 2000. 9(3): p. 183-8.
10. Minami, T. and W.C. Aird, Endothelial cell gene regulation. Trends Cardiovasc 
Med, 2005. 15(5): p. 174-84.
11. Aird, W.C., Endothelium as an organ system. Crit Care Med, 2004. 32(5 Suppl): 
p. S271-9.
12. Goncharov, N.V., et al., Markers and Biomarkers of Endothelium: When 
Something Is Rotten in the State. Oxid Med Cell Longev, 2017. 2017: p. 
9759735.
13. Ordonez, N.G., Immunohistochemical endothelial markers: a review. Adv Anat 
Pathol, 2012. 19(5): p. 281-95.
14. Woodfin, A., M.B. Voisin, and S. Nourshargh, PECAM-1: a multi-functional 
molecule in inflammation and vascular biology. Arterioscler Thromb Vasc Biol, 
2007. 27(12): p. 2514-23.
15. Newman, P.J., The biology of PECAM-1. J Clin Invest, 1997. 99(1): p. 3-8.
16. Huang, A.J., et al., Effects of human neutrophil chemotaxis across human 
endothelial cell monolayers on the permeability of these monolayers to ions and 
macromolecules. J Cell Physiol, 1988. 135(3): p. 355-66.
17. Springer, T.A., Traffic signals for lymphocyte recirculation and leukocyte 
emigration: the multistep paradigm. Cell, 1994. 76(2): p. 301-14.
18. Tousoulis, D., et al., The role of nitric oxide on endothelial function. Curr Vasc 
Pharmacol, 2012. 10(1): p. 4-18.
19. Luscher, T.F. and M. Barton, Biology of the endothelium. Clin Cardiol, 1997. 
20(11 Suppl 2): p. II-3-10.
20. van Hinsbergh, V.W. and G.P. van Nieuw Amerongen, Intracellular signalling 




21. Ballabh, P., A. Braun, and M. Nedergaard, The blood-brain barrier: an overview: 
structure, regulation, and clinical implications. Neurobiol Dis, 2004. 16(1): p. 1-
13.
22. Dvorak, A.M. and D. Feng, The vesiculo-vacuolar organelle (VVO). A new 
endothelial cell permeability organelle. J Histochem Cytochem, 2001. 49(4): p. 
419-32.
23. Wallez, Y. and P. Huber, Endothelial adherens and tight junctions in vascular 
homeostasis, inflammation and angiogenesis. Biochim Biophys Acta, 2008. 
1778(3): p. 794-809.
24. Bazzoni, G. and E. Dejana, Endothelial cell-to-cell junctions: molecular 
organization and role in vascular homeostasis. Physiol Rev, 2004. 84(3): p. 869-
901.
25. Dejana, E. and F. Orsenigo, Endothelial adherens junctions at a glance. J Cell 
Sci, 2013. 126(Pt 12): p. 2545-9.
26. Bazzoni, G., Endothelial tight junctions: permeable barriers of the vessel wall. 
Thromb Haemost, 2006. 95(1): p. 36-42.
27. Pardridge, W.M., The blood-brain barrier: bottleneck in brain drug development. 
NeuroRx, 2005. 2(1): p. 3-14.
28. Abbott, N.J., et al., Structure and function of the blood-brain barrier. Neurobiol 
Dis, 2010. 37(1): p. 13-25.
29. Wei, X.N., et al., An integrated mathematical model of thrombin-, histamine-and 
VEGF-mediated signalling in endothelial permeability. BMC Syst Biol, 2011. 5: 
p. 112.
30. Chen, D.C., Sepsis and Intestinal Microvascular Endothelial Dysfunction. Chin 
Med J (Engl), 2017. 130(10): p. 1137-1138.
31. Pober, J.S. and W.C. Sessa, Evolving functions of endothelial cells in 
inflammation. Nat Rev Immunol, 2007. 7(10): p. 803-15.
32. Barbieri, S.S., et al., Suppressing PTEN activity by tobacco smoke plus 
interleukin-1beta modulates dissociation of VE-cadherin/beta-catenin 
complexes in endothelium. Arterioscler Thromb Vasc Biol, 2008. 28(4): p. 732-
8.
33. Ince, C., et al., The Endothelium in Sepsis. Shock, 2016. 45(3): p. 259-70.
34. Choi, J.J., et al., Molecules of various pharmacologically-relevant sizes can 
cross the ultrasound-induced blood-brain barrier opening in vivo. Ultrasound 
Med Biol, 2010. 36(1): p. 58-67.
35. Alternative routes of drug administration--advantages and disadvantages 
(subject review). American Academy of Pediatrics. Committee on Drugs. 
Pediatrics, 1997. 100(1): p. 143-52.
36. Oller-Salvia, B., et al., Blood-brain barrier shuttle peptides: an emerging 
paradigm for brain delivery. Chem Soc Rev, 2016. 45(17): p. 4690-707.
37. Kreuter, J., Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv 
Rev, 2001. 47(1): p. 65-81.
38. Pardridge, W.M., Drug targeting to the brain. Pharm Res, 2007. 24(9): p. 1733-
44.
39. Chatzizisis, Y.S., et al., Role of endothelial shear stress in the natural history of 
coronary atherosclerosis and vascular remodeling: molecular, cellular, and 
References
119
vascular behavior. J Am Coll Cardiol, 2007. 49(25): p. 2379-93.
40. Davies, P.F., et al., Turbulent fluid shear stress induces vascular endothelial cell 
turnover in vitro. Proc Natl Acad Sci U S A, 1986. 83(7): p. 2114-7.
41. Davies, P.F., How Do Vascular Endothelial Cells Respond to Flow? Vol. 4. 
1989. 22-25.
42. Li, Y.S., J.H. Haga, and S. Chien, Molecular basis of the effects of shear stress 
on vascular endothelial cells. J Biomech, 2005. 38(10): p. 1949-71.
43. Silkworth, J.B., W.E. Stehbens, and D. Phil, The Shape of Endothelial Cells in 
En Face Preparations of Rabbit Blood Vessels. Angiology, 1975. 26(6): p. 474-
487.
44. Nerem, R.M., M.J. Levesque, and J.F. Cornhill, Vascular endothelial 
morphology as an indicator of the pattern of blood flow. J Biomech Eng, 1981. 
103(3): p. 172-6.
45. Flaherty, J.T., et al., Endothelial nuclear patterns in the canine arterial tree with 
particular reference to hemodynamic events. Circ Res, 1972. 30(1): p. 23-33.
46. Karlon, W.J., et al., Measurement of orientation and distribution of cellular 
alignment and cytoskeletal organization. Ann Biomed Eng, 1999. 27(6): p. 712-
20.
47. Girard, P.R. and R.M. Nerem, Shear stress modulates endothelial cell 
morphology and F-actin organization through the regulation of focal adhesion-
associated proteins. J Cell Physiol, 1995. 163(1): p. 179-93.
48. Malek, A.M. and S. Izumo, Mechanism of endothelial cell shape change and 
cytoskeletal remodeling in response to fluid shear stress. J Cell Sci, 1996. 109 
( Pt 4): p. 713-26.
49. Nerem, R.M., et al., The study of the influence of flow on vascular endothelial 
biology. Am J Med Sci, 1998. 316(3): p. 169-75.
50. Dimmeler, S., et al., Shear stress inhibits apoptosis of human endothelial cells. 
FEBS Lett, 1996. 399(1-2): p. 71-4.
51. Morigi, M., et al., Fluid shear stress modulates surface expression of adhesion 
molecules by endothelial cells. Blood, 1995. 85(7): p. 1696-703.
52. Nagel, T., et al., Shear stress selectively upregulates intercellular adhesion 
molecule-1 expression in cultured human vascular endothelial cells. J Clin 
Invest, 1994. 94(2): p. 885-91.
53. Sampath, R., et al., Shear stress-mediated changes in the expression of 
leukocyte adhesion receptors on human umbilical vein endothelial cells in vitro. 
Ann Biomed Eng, 1995. 23(3): p. 247-56.
54. Chappell, D.C., et al., Oscillatory shear stress stimulates adhesion molecule 
expression in cultured human endothelium. Circ Res, 1998. 82(5): p. 532-9.
55. Chistiakov, D.A., A.N. Orekhov, and Y.V. Bobryshev, Effects of shear stress on 
endothelial cells: go with the flow. Acta Physiol (Oxf), 2017. 219(2): p. 382-408.
56. Collins, N.T., et al., Cyclic strain-mediated regulation of vascular endothelial 
occludin and ZO-1: influence on intercellular tight junction assembly and 
function. Arterioscler Thromb Vasc Biol, 2006. 26(1): p. 62-8.
57. Davies, P.F., Flow-mediated endothelial mechanotransduction. Physiol Rev, 
1995. 75(3): p. 519-60.
58. Conway, D. and M.A. Schwartz, Lessons from the endothelial junctional 
mechanosensory complex. F1000 Biol Rep, 2012. 4: p. 1.
References
120
59. Silberman, M., et al., Shear stress-induced transcriptional regulation via hybrid 
promoters as a potential tool for promoting angiogenesis. Angiogenesis, 2009. 
12(3): p. 231-42.
60. Zhou, J., et al., Force-specific activation of Smad1/5 regulates vascular 
endothelial cell cycle progression in response to disturbed flow. Proc Natl Acad 
Sci U S A, 2012. 109(20): p. 7770-5.
61. Barakat, A. and D. Lieu, Differential responsiveness of vascular endothelial cells 
to different types of fluid mechanical shear stress. Cell Biochem Biophys, 2003. 
38(3): p. 323-43.
62. Chiu, J.J. and S. Chien, Effects of disturbed flow on vascular endothelium: 
pathophysiological basis and clinical perspectives. Physiol Rev, 2011. 91(1): p. 
327-87.
63. Singhal, A.K., et al., Role of Endothelial Cells in Myocardial Ischemia-
Reperfusion Injury. Vasc Dis Prev, 2010. 7: p. 1-14.
64. Wang, A.Z., R. Langer, and O.C. Farokhzad, Nanoparticle delivery of cancer 
drugs. Annu Rev Med, 2012. 63: p. 185-98.
65. Cicha, I., Strategies to enhance nanoparticle endothelial interactions under flow. 
Journal of Cellular Biotechnology, 2016. 1(2): p. 191-208.
66. Singh, R. and J.W. Lillard, Jr., Nanoparticle-based targeted drug delivery. Exp 
Mol Pathol, 2009. 86(3): p. 215-23.
67. Frohlich, E., The role of surface charge in cellular uptake and cytotoxicity of 
medical nanoparticles. Int J Nanomedicine, 2012. 7: p. 5577-91.
68. Wilczewska, A.Z., et al., Nanoparticles as drug delivery systems. 
Pharmacological Reports, 2012. 64(5): p. 1020-1037.
69. Ghorbani, H.R., A Review of Methods for Synthesis of Al Nanoparticles. Oriental 
Journal of Chemistry, 2014. 30(4).
70. Kralj, S. and D. Makovec, Magnetic Assembly of Superparamagnetic Iron Oxide 
Nanoparticle Clusters into Nanochains and Nanobundles. ACS Nano, 2015. 
9(10): p. 9700-9707.
71. Sun, Y. and Y. Xia, Shape-controlled synthesis of gold and silver nanoparticles. 
Science, 2002. 298(5601): p. 2176-9.
72. Berg, J.M., et al., The relationship between pH and zeta potential of  30 nm 
metal oxide nanoparticle suspensions relevant to in vitro toxicological 
evaluations. Nanotoxicology, 2009. 3(4): p. 276-283.
73. De Jong, W.H. and P.J. Borm, Drug delivery and nanoparticles:applications and 
hazards. Int J Nanomedicine, 2008. 3(2): p. 133-49.
74. Treuel, L., X. Jiang, and G.U. Nienhaus, New views on cellular uptake and 
trafficking of manufactured nanoparticles. J R Soc Interface, 2013. 10(82): p. 
20120939.
75. Perry, J.L., et al., PRINT: a novel platform toward shape and size specific 
nanoparticle theranostics. Acc Chem Res, 2011. 44(10): p. 990-8.
76. Derry, M.J., L.A. Fielding, and S.P. Armes, Polymerization-induced self-
assembly of block copolymer nanoparticles via RAFT non-aqueous dispersion 
polymerization. Progress in Polymer Science, 2016. 52: p. 1-18.
77. Cole, A.J., V.C. Yang, and A.E. David, Cancer theranostics: the rise of targeted 
magnetic nanoparticles. Trends Biotechnol, 2011. 29(7): p. 323-32.
78. Nakamura, Y., et al., Nanodrug Delivery: Is the Enhanced Permeability and 
References
121
Retention Effect Sufficient for Curing Cancer? Bioconjugate Chemistry, 2016. 
27(10): p. 2225-2238.
79. Levesque, M.J. and R.M. Nerem, The elongation and orientation of cultured 
endothelial cells in response to shear stress. J Biomech Eng, 1985. 107(4): p. 
341-7.
80. Dewey, C.F., Jr., et al., The dynamic response of vascular endothelial cells to 
fluid shear stress. J Biomech Eng, 1981. 103(3): p. 177-85.
81. Davies, P.F. and S.C. Tripathi, Mechanical stress mechanisms and the cell. An 
endothelial paradigm. Circ Res, 1993. 72(2): p. 239-45.
82. Koo, A., C.F. Dewey, Jr., and G. Garcia-Cardena, Hemodynamic shear stress 
characteristic of atherosclerosis-resistant regions promotes glycocalyx 
formation in cultured endothelial cells. Am J Physiol Cell Physiol, 2013. 304(2): 
p. C137-46.
83. Arisaka, T., et al., Effects of shear stress on glycosaminoglycan synthesis in 
vascular endothelial cells. Ann N Y Acad Sci, 1995. 748: p. 543-54.
84. Yoshida, Y., et al., Hemodynamic-force-induced difference of interendothelial 
junctional complexes. Ann N Y Acad Sci, 1995. 748: p. 104-20; discussion 120-
1.
85. Cucullo, L., et al., The role of shear stress in Blood-Brain Barrier endothelial 
physiology. BMC Neurosci, 2011. 12: p. 40.
86. Kang, T., et al., Effects of shear stress on the cellular distribution of polystyrene 
nanoparticles in a biomimetic microfluidic system. Journal of Drug Delivery 
Science and Technology, 2016. 31: p. 130-136.
87. Torchilin, V.P., Cell penetrating peptide-modified pharmaceutical nanocarriers 
for intracellular drug and gene delivery. Biopolymers, 2008. 90(5): p. 604-10.
88. Fang, I.J., et al., Ligand conformation dictates membrane and endosomal 
trafficking of arginine-glycine-aspartate (RGD)-functionalized mesoporous silica 
nanoparticles. Chemistry, 2012. 18(25): p. 7787-92.
89. Antosova, A., et al., Amino Acid Functionalized Superparamagnetic 
Nanoparticles Inhibit Lysozyme Amyloid Fibrillization. Chemistry, 2019.
90. Kulandaisamy, A.J. and J.B.B. Rayappan, Significance of Nanoparticles and the 
Role of Amino Acids in Structuring Them-A Review. J Nanosci Nanotechnol, 
2018. 18(8): p. 5222-5233.
91. Raula, J., et al., Preparation of amino acid nanoparticles at varying saturation 
conditions in an aerosol flow reactor. Journal of Nanoparticle Research, 2012. 
14(7): p. 986.
92. Sun, E.Y., et al., Development of Nanoparticle Libraries for Biosensing. 
Bioconjugate Chemistry, 2006. 17(1): p. 109-113.
93. Whitesides, G.M., The origins and the future of microfluidics. Nature, 2006. 
442(7101): p. 368-73.
94. Krueger, J.W., D.F. Young, and N.R. Cholvin, An in vitro study of flow response 
by cells. J Biomech, 1971. 4(1): p. 31-6.
95. DePaola, N., et al., Vascular endothelium responds to fluid shear stress 
gradients. Arterioscler Thromb, 1992. 12(11): p. 1254-7.
96. Bhatia, S.N. and D.E. Ingber, Microfluidic organs-on-chips. Nature 
Biotechnology, 2014. 32(8): p. 760-772.
97. Lee, A., The third decade of microfluidics. Lab Chip, 2013. 13(9): p. 1660-1.
References
122
98. Young, E.W. and C.A. Simmons, Macro- and microscale fluid flow systems for 
endothelial cell biology. Lab Chip, 2010. 10(2): p. 143-60.
99. Huh, D., G.A. Hamilton, and D.E. Ingber, From 3D cell culture to organs-on-
chips. Trends Cell Biol, 2011. 21(12): p. 745-54.
100. van Midwoud, P.M., et al., Comparison of biocompatibility and adsorption 
properties of different plastics for advanced microfluidic cell and tissue culture 
models. Anal Chem, 2012. 84(9): p. 3938-44.
101. Berthier, E., E.W. Young, and D. Beebe, Engineers are from PDMS-land, 
Biologists are from Polystyrenia. Lab Chip, 2012. 12(7): p. 1224-37.
102. Huh, D., et al., Reconstituting organ-level lung functions on a chip. Science, 
2010. 328(5986): p. 1662-8.
103. Herland, A., et al., Distinct Contributions of Astrocytes and Pericytes to 
Neuroinflammation Identified in a 3D Human Blood-Brain Barrier on a Chip. 
PLoS One, 2016. 11(3): p. e0150360.
104. Jang, K.J., et al., Human kidney proximal tubule-on-a-chip for drug transport 
and nephrotoxicity assessment. Integr Biol (Camb), 2013. 5(9): p. 1119-29.
105. Booth, R. and H. Kim, Characterization of a microfluidic in vitro model of the 
blood-brain barrier (muBBB). Lab Chip, 2012. 12(10): p. 1784-92.
106. Wong, K.H., et al., Microfluidic models of vascular functions. Annu Rev Biomed 
Eng, 2012. 14: p. 205-30.
107. Eddington, D.T., J.P. Puccinelli, and D.J. Beebe, Thermal aging and reduced 
hydrophobic recovery of polydimethylsiloxane. Sensors and Actuators B-
Chemical, 2006. 114(1): p. 170-172.
108. Toepke, M.W. and D.J. Beebe, PDMS absorption of small molecules and 
consequences in microfluidic applications. Lab on a Chip, 2006. 6(12): p. 1484-
1486.
109. Regehr, K.J., et al., Biological implications of polydimethylsiloxane-based 
microfluidic cell culture. Lab on a Chip, 2009. 9(15): p. 2132-2139.
110. Thuenauer, R., E. Rodriguez-Boulan, and W. Romer, Microfluidic approaches 
for epithelial cell layer culture and characterisation. Analyst, 2014. 139(13): p. 
3206-18.
111. Kutz, M., Biomedical engineering and design handbook. 2nd ed. 2009, New 
York: McGraw-Hill.
112. Ku, D.N., Blood flow in arteries. Annual Review of Fluid Mechanics, 1997. 29: 
p. 399-434.
113. Reneman, R.S., T. Arts, and A.P. Hoeks, Wall shear stress--an important 
determinant of endothelial cell function and structure--in the arterial system in 
vivo. Discrepancies with theory. J Vasc Res, 2006. 43(3): p. 251-69.
114. Papaioannou, T.G. and C. Stefanadis, Vascular wall shear stress: basic 
principles and methods. Hellenic J Cardiol, 2005. 46(1): p. 9-15.
115. Le-Cong, P. and B.W. Zweifach, In vivo and in vitro velocity measurements in 
microvasculature with a laser. Microvasc Res, 1979. 17(2): p. 131-41.
116. Cheng, C., et al., Large variations in absolute wall shear stress levels within one 
species and between species. Atherosclerosis, 2007. 195(2): p. 225-35.
117. Gupta, N., et al., Microfluidics-based 3D cell culture models: Utility in novel drug 
discovery and delivery research. Bioeng Transl Med, 2016. 1(1): p. 63-81.
References
123
118. Takayama, S., et al., Subcellular positioning of small molecules. Nature, 2001. 
411(6841): p. 1016.
119. Carraro, A., et al., In vitro analysis of a hepatic device with intrinsic 
microvascular-based channels. Biomed Microdevices, 2008. 10(6): p. 795-805.
120. Rennert, K., et al., A microfluidically perfused three dimensional human liver 
model. Biomaterials, 2015. 71: p. 119-131.
121. Imura, Y., et al., A microfluidic system to evaluate intestinal absorption. Anal 
Sci, 2009. 25(12): p. 1403-7.
122. Kimura, H., et al., An integrated microfluidic system for long-term perfusion 
culture and on-line monitoring of intestinal tissue models. Lab Chip, 2008. 8(5): 
p. 741-6.
123. Jang, K.J. and K.Y. Suh, A multi-layer microfluidic device for efficient culture 
and analysis of renal tubular cells. Lab Chip, 2010. 10(1): p. 36-42.
124. Jang, K.J., et al., Fluid-shear-stress-induced translocation of aquaporin-2 and 
reorganization of actin cytoskeleton in renal tubular epithelial cells. Integr Biol 
(Camb), 2011. 3(2): p. 134-41.
125. Russell, W.M.S. and R.L. Burch, The principles of humane experimental 
technique. 1959, London,: Methuen. 238 p.
126. Mosig, A.S., Organ-on-chip models: new opportunities for biomedical research. 
Future science OA, 2016. 3(2): p. FSO130-FSO130.
127. Getz, G.S. and C.A. Reardon, Animal models of atherosclerosis. Arterioscler 
Thromb Vasc Biol, 2012. 32(5): p. 1104-15.
128. Delire, B., P. Stärkel, and I. Leclercq, Animal Models for Fibrotic Liver Diseases: 
What We Have, What We Need, and What Is under Development. Journal of 
clinical and translational hepatology, 2015. 3(1): p. 53-66.
129. Liu, T., F.G. De Los Santos, and S.H. Phan, The Bleomycin Model of Pulmonary 
Fibrosis. Methods Mol Biol, 2017. 1627: p. 27-42.
130. Dinardo, C.L., et al., Vascular smooth muscle cells exhibit a progressive loss of 
rigidity with serial culture passaging. Biorheology, 2012. 49(5-6): p. 365-73.
131. Macarak, E.J. and P.S. Howard, Adhesion of endothelial cells to extracellular 
matrix proteins. J Cell Physiol, 1983. 116(1): p. 76-86.
132. Halka, A.T., et al., The effects of stretch on vascular smooth muscle cell 
phenotype in vitro. Cardiovasc Pathol, 2008. 17(2): p. 98-102.
133. Shyu, K.G., Cellular and molecular effects of mechanical stretch on vascular 
cells and cardiac myocytes. Clin Sci (Lond), 2009. 116(5): p. 377-89.
134. Chamley-Campbell, J., G.R. Campbell, and R. Ross, The smooth muscle cell in 
culture. Physiol Rev, 1979. 59(1): p. 1-61.
135. Powell, R.J., et al., Endothelial cell effect on smooth muscle cell collagen 
synthesis. J Surg Res, 1997. 69(1): p. 113-8.
136. Lauffenburger, D.A. and L.G. Griffith, Who's got pull around here? Cell 
organization in development and tissue engineering. Proc Natl Acad Sci U S A, 
2001. 98(8): p. 4282-4.
137. Locker, A., [Animal testing ethics and human testing. Thoughts on our conduct 
with and our relationship to animals]. ALTEX, 2004. 21(4): p. 221-6.
138. Nurunnabi, A., R. Afroz, and S. Alam, Ethical Debate on Animal Research. 
Bangladesh Journal of Bioethics, 2013. 4(3): p. 11-18.
References
124
139. DeGrazia, D. and J. Sebo, Necessary conditions for morally responsible animal 
research. Camb Q Healthc Ethics, 2015. 24(4): p. 420-30.
140. Buller, T., Animal minds and neuroimaging--bridging the gap between science 
and ethics? Camb Q Healthc Ethics, 2014. 23(2): p. 173-81.
141. Foex, B.A., The ethics of animal experimentation. Emerg Med J, 2007. 24(11): 
p. 750-1.
142. Reagan-Shaw, S., M. Nihal, and N. Ahmad, Dose translation from animal to 
human studies revisited. Faseb j, 2008. 22(3): p. 659-61.
143. Mak, I.W., N. Evaniew, and M. Ghert, Lost in translation: animal models and 
clinical trials in cancer treatment. Am J Transl Res, 2014. 6(2): p. 114-8.
144. Shanks, N., R. Greek, and J. Greek, Are animal models predictive for humans? 
Philos Ethics Humanit Med, 2009. 4: p. 2.
145. Collins, F.S., Of Mice, Men, and Medicine. 2013.
146. Plenge, R.M., E.M. Scolnick, and D. Altshuler, Validating therapeutic targets 
through human genetics. Nat Rev Drug Discov, 2013. 12(8): p. 581-94.
147. Green, S.B., Can animal data translate to innovations necessary for a new era 
of patient-centred and individualised healthcare? Bias in preclinical animal 
research. BMC Med Ethics, 2015. 16: p. 53.
148. Andersson, H. and A. van den Berg, Microfabrication and microfluidics for tissue 
engineering: state of the art and future opportunities. Lab Chip, 2004. 4(2): p. 
98-103.
149. Davies, P.F., J. Zilberberg, and B.P. Helmke, Spatial microstimuli in endothelial 
mechanosignaling. Circ Res, 2003. 92(4): p. 359-70.
150. Eskin, S.G., et al., Response of cultured endothelial cells to steady flow. 
Microvasc Res, 1984. 28(1): p. 87-94.
151. Yuan, S.Y. and R.R. Rigor, Regulation of Endothelial Barrier Function. 
Regulation of Endothelial Barrier Function. 2010, San Rafael (CA).
152. Komarova, Y. and A.B. Malik, Regulation of endothelial permeability via 
paracellular and transcellular transport pathways. Annu Rev Physiol, 2010. 72: 
p. 463-93.
153. Shi, C. and E.G. Pamer, Monocyte recruitment during infection and 
inflammation. Nat Rev Immunol, 2011. 11(11): p. 762-74.
154. Lin, A., et al., Shear-regulated uptake of nanoparticles by endothelial cells and 
development of endothelial-targeting nanoparticles. J Biomed Mater Res A, 
2010. 93(3): p. 833-42.
155. Davies, P.F., How Do Vascular Endothelial-Cells Respond to Flow. News in 
Physiological Sciences, 1989. 4: p. 22-25.
156. Shao, J., et al., Integrated microfluidic chip for endothelial cells culture and 
analysis exposed to a pulsatile and oscillatory shear stress. Lab Chip, 2009. 
9(21): p. 3118-25.
157. Estrada, R., et al., Microfluidic endothelial cell culture model to replicate 
disturbed flow conditions seen in atherosclerosis susceptible regions. 
Biomicrofluidics, 2011. 5(3): p. 32006-3200611.
158. Garcia-Cardena, G., et al., Biomechanical activation of vascular endothelium as 




159. Cockcroft, N.Y., et al., An in vitro perfusion system to examine the responses of 
endothelial cells to simulated flow and inflammatory stimulation. Altern Lab 
Anim, 2009. 37(6): p. 657-69.
160. Zarins, C.K., et al., Carotid bifurcation atherosclerosis. Quantitative correlation 
of plaque localization with flow velocity profiles and wall shear stress. Circ Res, 
1983. 53(4): p. 502-14.
161. Senis, Y.A., et al., Changes in the pattern of distribution of von Willebrand factor 
in rat aortic endothelial cells following thrombin generation in vivo. Br J 
Haematol, 1996. 93(1): p. 195-203.
162. Sporn, L.A., V.J. Marder, and D.D. Wagner, Inducible secretion of large, 
biologically potent von Willebrand factor multimers. Cell, 1986. 46(2): p. 185-90.
163. Valentijn, K.M., et al., Multigranular exocytosis of Weibel-Palade bodies in 
vascular endothelial cells. Blood, 2010. 116(10): p. 1807-16.
164. Xiong, Y., et al., Hypertensive stretch regulates endothelial exocytosis of 
Weibel-Palade bodies through VEGF receptor 2 signaling pathways. Cell Res, 
2013. 23(6): p. 820-34.
165. Huang, R.H., et al., Assembly of Weibel-Palade body-like tubules from N-
terminal domains of von Willebrand factor. Proc Natl Acad Sci U S A, 2008. 
105(2): p. 482-7.
166. Michaux, G., et al., The physiological function of von Willebrand's factor 
depends on its tubular storage in endothelial Weibel-Palade bodies. Dev Cell, 
2006. 10(2): p. 223-32.
167. Federici, A.B. and P.M. Mannucci, Management of inherited von Willebrand 
disease in 2007. Ann Med, 2007. 39(5): p. 346-58.
168. McDonald, J.C. and G.M. Whitesides, Poly(dimethylsiloxane) as a material for 
fabricating microfluidic devices. Acc Chem Res, 2002. 35(7): p. 491-9.
169. Melin, J. and S.R. Quake, Microfluidic large-scale integration: The evolution of 
design rules for biological automation. Annual Review of Biophysics and 
Biomolecular Structure, 2007. 36: p. 213-231.
170. Zhao, S., et al., Synergistic effects of fluid shear stress and cyclic circumferential 
stretch on vascular endothelial cell morphology and cytoskeleton. Arterioscler 
Thromb Vasc Biol, 1995. 15(10): p. 1781-6.
171. Pappelbaum, K.I., et al., Ultralarge von Willebrand factor fibers mediate luminal 
Staphylococcus aureus adhesion to an intact endothelial cell layer under shear 
stress. Circulation, 2013. 128(1): p. 50-9.
172. Stewart, R.J., T.S. Kashour, and P.A. Marsden, Vascular endothelial platelet 
endothelial adhesion molecule-1 (PECAM-1) expression is decreased by TNF-
alpha and IFN-gamma. Evidence for cytokine-induced destabilization of 
messenger ribonucleic acid transcripts in bovine endothelial cells. J Immunol, 
1996. 156(3): p. 1221-8.
173. Fernandez-Martin, L., et al., Crosstalk Between Reticular Adherens Junctions 
and Platelet Endothelial Cell Adhesion Molecule-1 Regulates Endothelial 
Barrier Function. Arteriosclerosis Thrombosis and Vascular Biology, 2012. 
32(8): p. E90-U141.
174. Capaldo, C.T. and A. Nusrat, Cytokine regulation of tight junctions. Biochimica 
Et Biophysica Acta-Biomembranes, 2009. 1788(4): p. 864-871.
175. Stroka, K.M., J.A. Vaitkus, and H. Aranda-Espinoza, Endothelial cells undergo 
morphological, biomechanical, and dynamic changes in response to tumor 
References
126
necrosis factor-alpha. Eur Biophys J, 2012. 41(11): p. 939-47.
176. Madge, L.A. and J.S. Pober, TNF signaling in vascular endothelial cells. Exp 
Mol Pathol, 2001. 70(3): p. 317-25.
177. Pober, J.S., Endothelial activation: intracellular signaling pathways. Arthritis 
Res, 2002. 4 Suppl 3: p. S109-16.
178. Tsao, P.S., et al., Fluid flow inhibits endothelial adhesiveness. Nitric oxide and 
transcriptional regulation of VCAM-1. Circulation, 1996. 94(7): p. 1682-9.
179. Chiu, J.J., et al., Shear stress increases ICAM-1 and decreases VCAM-1 and 
E-selectin expressions induced by tumor necrosis factor-[alpha] in endothelial 
cells. Arterioscler Thromb Vasc Biol, 2004. 24(1): p. 73-9.
180. Partridge, J., et al., Laminar shear stress acts as a switch to regulate divergent 
functions of NF-kappaB in endothelial cells. FASEB J, 2007. 21(13): p. 3553-
61.
181. De Caterina, R., et al., Nitric oxide decreases cytokine-induced endothelial 
activation. Nitric oxide selectively reduces endothelial expression of adhesion 
molecules and proinflammatory cytokines. J Clin Invest, 1995. 96(1): p. 60-8.
182. Nakadate, H., et al., Combinations of Hydrostatic Pressure and Shear Stress 
Time-dependently Decrease E-selectin, VCAM-1 and ICAM-1 Expression 
Induced by Tumor Necrosis Factor-Alpha in Cultured Endothelial Cells. Journal 
of Biomechanical Science and Engineering, 2012. 7(2): p. 118-129.
183. Etzioni, A., Adhesion molecules--their role in health and disease. Pediatr Res, 
1996. 39(2): p. 191-8.
184. Khalili, A.A. and M.R. Ahmad, A Review of Cell Adhesion Studies for Biomedical 
and Biological Applications. Int J Mol Sci, 2015. 16(8): p. 18149-84.
185. Gupta, V.K., et al., Multi-scale simulation of L-selectin-PSGL-1-dependent 
homotypic leukocyte binding and rupture. Biomechanics and Modeling in 
Mechanobiology, 2010. 9(5): p. 613-627.
186. Chen, W.C., A.X. Zhang, and S.D. Li, Limitations and niches of the active 
targeting approach for nanoparticle drug delivery Eur J Nanomed, 2012. 4(2-4): 
p. 89-93.
187. Dobrovolskaia, M.A., et al., Preclinical studies to understand nanoparticle 
interaction with the immune system and its potential effects on nanoparticle 
biodistribution. Mol Pharm, 2008. 5(4): p. 487-95.
188. Samuel, S.P., et al., Multifactorial determinants that govern nanoparticle uptake 
by human endothelial cells under flow. International Journal of Nanomedicine, 
2012. 7: p. 2943-2956.
189. Yang, H., et al., VCAM-1-targeted core/shell nanoparticles for selective 
adhesion and delivery to endothelial cells with lipopolysaccharide-induced 
inflammation under shear flow and cellular magnetic resonance imaging in vitro. 
Int J Nanomedicine, 2013. 8: p. 1897-906.
190. Di, L., The role of drug metabolizing enzymes in clearance. Expert Opin Drug 
Metab Toxicol, 2014. 10(3): p. 379-93.
191. Zanger, U.M. and M. Schwab, Cytochrome P450 enzymes in drug metabolism: 
regulation of gene expression, enzyme activities, and impact of genetic 
variation. Pharmacol Ther, 2013. 138(1): p. 103-41.




193. Bilzer, M., F. Roggel, and A.L. Gerbes, Role of Kupffer cells in host defense and 
liver disease. Liver Int, 2006. 26(10): p. 1175-86.
194. Press, A.T., et al., Cell type-specific delivery of short interfering RNAs by dye-
functionalised theranostic nanoparticles. Nat Commun, 2014. 5: p. 5565.
195. Alizadeh, D., et al., Tumor-associated macrophages are predominant carriers 
of cyclodextrin-based nanoparticles into gliomas. Nanomedicine-
Nanotechnology Biology and Medicine, 2010. 6(2): p. 382-390.
196. An, F., et al., Organ-on-a-Chip: New Platform for Biological Analysis. Anal Chem 
Insights, 2015. 10: p. 39-45.
197. Stanimirovic, D.B., et al., Blood-brain barrier models: in vitro to in vivo translation 
in preclinical development of CNS-targeting biotherapeutics. Expert Opin Drug 
Discov, 2015. 10(2): p. 141-55.
198. He, Y., et al., Cell-culture models of the blood-brain barrier. Stroke, 2014. 45(8): 
p. 2514-26.
199. Veszelka, S., et al., Blood-brain barrier co-culture models to study nanoparticle 
penetration: focus on co-culture systems. Acta Biologica Szegediensis, 2015. 
59(Suppl. 2): p. 157-168.
200. Wong, A.D., et al., The blood-brain barrier: an engineering perspective. Front 
Neuroeng, 2013. 6: p. 7.
201. van der Helm, M.W., et al., Microfluidic organ-on-chip technology for blood-brain 
barrier research. Tissue Barriers, 2016. 4(1): p. e1142493.
202. Prabhakarpandian, B., et al., SyM-BBB: a microfluidic Blood Brain Barrier 
model. Lab Chip, 2013. 13(6): p. 1093-101.
203. Walter, F.R., et al., A versatile lab-on-a-chip tool for modeling biological barriers. 
Sensors and Actuators B-Chemical, 2016. 222: p. 1209-1219.
204. Brown, J.A., et al., Recreating blood-brain barrier physiology and structure on 
chip: A novel neurovascular microfluidic bioreactor. Biomicrofluidics, 2015. 9(5): 
p. 054124.
205. Weksler, B.B., et al., Blood-brain barrier-specific properties of a human adult 
brain endothelial cell line. FASEB J, 2005. 19(13): p. 1872-4.
206. Weksler, B., I.A. Romero, and P.O. Couraud, The hCMEC/D3 cell line as a 
model of the human blood brain barrier. Fluids Barriers CNS, 2013. 10(1): p. 16.
207. Galbraith, C.G., R. Skalak, and S. Chien, Shear stress induces spatial 
reorganization of the endothelial cell cytoskeleton. Cell Motil Cytoskeleton, 
1998. 40(4): p. 317-30.
208. Cucullo, L., et al., Immortalized human brain endothelial cells and flow-based 
vascular modeling: a marriage of convenience for rational neurovascular 
studies. J Cereb Blood Flow Metab, 2008. 28(2): p. 312-28.
209. Stevenson, B.R., et al., Identification of ZO-1: a high molecular weight 
polypeptide associated with the tight junction (zonula occludens) in a variety of 
epithelia. J Cell Biol, 1986. 103(3): p. 755-66.
210. Griep, L.M., et al., BBB on chip: microfluidic platform to mechanically and 
biochemically modulate blood-brain barrier function. Biomed Microdevices, 
2013. 15(1): p. 145-50.
211. Suidan, G.L., et al., Endothelial Von Willebrand factor promotes blood-brain 
barrier flexibility and provides protection from hypoxia and seizures in mice. 
Arterioscler Thromb Vasc Biol, 2013. 33(9): p. 2112-20.
References
128
212. Tran, K.A., et al., Endothelial beta-Catenin Signaling Is Required for Maintaining 
Adult Blood-Brain Barrier Integrity and Central Nervous System Homeostasis. 
Circulation, 2016. 133(2): p. 177-86.
213. Eiraku, M. and Y. Sasai, Mouse embryonic stem cell culture for generation of 
three-dimensional retinal and cortical tissues. Nat Protoc, 2011. 7(1): p. 69-79.
214. Englund, C., et al., Pax6, Tbr2, and Tbr1 are expressed sequentially by radial 
glia, intermediate progenitor cells, and postmitotic neurons in developing 
neocortex. J Neurosci, 2005. 25(1): p. 247-51.
215. Bayatti, N., et al., Progressive loss of PAX6, TBR2, NEUROD and TBR1 mRNA 
gradients correlates with translocation of EMX2 to the cortical plate during 
human cortical development. Eur J Neurosci, 2008. 28(8): p. 1449-56.
216. Sansom, S.N., et al., The level of the transcription factor Pax6 is essential for 
controlling the balance between neural stem cell self-renewal and 
neurogenesis. PLoS Genet, 2009. 5(6): p. e1000511.
217. Sessa, A., et al., Tbr2 directs conversion of radial glia into basal precursors and 
guides neuronal amplification by indirect neurogenesis in the developing 
neocortex. Neuron, 2008. 60(1): p. 56-69.
218. Bedogni, F., et al., Tbr1 regulates regional and laminar identity of postmitotic 
neurons in developing neocortex. Proc Natl Acad Sci U S A, 2010. 107(29): p. 
13129-34.
219. Cho, H., et al., Three-Dimensional Blood-Brain Barrier Model for in vitro Studies 
of Neurovascular Pathology. Sci Rep, 2015. 5: p. 15222.
220. Carpentier, P.A., et al., Stereotypical alterations in cortical patterning are 
associated with maternal illness-induced placental dysfunction. J Neurosci, 
2013. 33(43): p. 16874-88.
221. Tronnes, A.A., et al., Effects of Lipopolysaccharide and Progesterone 
Exposures on Embryonic Cerebral Cortex Development in Mice. Reprod Sci, 
2016. 23(6): p. 771-8.
222. Soumiya, H., H. Fukumitsu, and S. Furukawa, Prenatal immune challenge 
compromises the normal course of neurogenesis during development of the 
mouse cerebral cortex. J Neurosci Res, 2011. 89(10): p. 1575-85.
223. Luissint, A.C., et al., Tight junctions at the blood brain barrier: physiological 
architecture and disease-associated dysregulation. Fluids Barriers CNS, 2012. 
9(1): p. 23.
224. Muoio, V., P.B. Persson, and M.M. Sendeski, The neurovascular unit - concept 
review. Acta Physiol (Oxf), 2014. 210(4): p. 790-8.
225. Correale, J. and A. Villa, Cellular elements of the blood-brain barrier. 
Neurochem Res, 2009. 34(12): p. 2067-77.
226. Kannan, R., et al., Evidence for carrier-mediated transport of glutathione across 
the blood-brain barrier in the rat. J Clin Invest, 1990. 85(6): p. 2009-13.
227. Kannan, R., et al., GSH transport in human cerebrovascular endothelial cells 
and human astrocytes: evidence for luminal localization of Na+-dependent GSH 
transport in HCEC. Brain Res, 2000. 852(2): p. 374-82.
228. Kafedjiiski, K., et al., Synthesis and in vitro characterization of a novel 
poly(acrylic acid)-glutathione conjugate. Journal of Drug Delivery Science and 
Technology, 2005. 15(6): p. 411-417.
229. More, S.S. and R. Vince, Design, synthesis and biological evaluation of 
glutathione peptidomimetics as components of anti-Parkinson prodrugs. Journal 
References
129
of Medicinal Chemistry, 2008. 51(15): p. 4581-4588.
230. Raval, N., et al., Development of glutathione-conjugated asiatic acid-loaded 
bovine serum albumin nanoparticles for brain-targeted drug delivery. J Pharm 
Pharmacol, 2015. 67(11): p. 1503-11.
231. Grover, A., A. Hirani, and V. Sutariya, Blood-Brain Barrier Permeation of 
Glutathione-Coated Nanoparticle. SOJ Pharm PharmSci, 2014. 1(1): p. 4.
232. Booth, R. and H. Kim, Permeability analysis of neuroactive drugs through a 
dynamic microfluidic in vitro blood-brain barrier model. Ann Biomed Eng, 2014. 
42(12): p. 2379-91.
233. Berg, C., Quantitative analysis of nanoparticle transport through in vitro blood-
brain barrier models. Tissue Barriers, 2016. 4(1): p. e1143545.
234. Grabrucker, A.M., et al., Nanoparticle transport across the blood brain barrier. 
Tissue Barriers, 2016. 4(1): p. e1153568.
235. Huang, A.J., et al., Effects of Human Neutrophil Chemotaxis across Human-
Endothelial Cell Monolayers on the Permeability of These Monolayers to Ions 
and Macromolecules. Journal of Cellular Physiology, 1988. 135(3): p. 355-366.
236. Patsch, C., et al., Generation of vascular endothelial and smooth muscle cells 
from human pluripotent stem cells. Nat Cell Biol, 2015. 17(8): p. 994-1003.
237. van Beveren, L., et al. Indium Tin Oxide film characterization using the classical 
Hall Effect. in CONFERENCE ON OPTOELECTRONIC AND 
MICROELECTRONIC MATERIALS AND DEVICES (COMMAD 2014). 2014.
238. Choi, E., et al., Formation of hydrogel membranes in microchannels and its 
applications. 2011.
239. Lou, Y.-R., et al., The use of nanofibrillar cellulose hydrogel as a flexible three-
dimensional model to culture human pluripotent stem cells. Stem cells and 
development, 2014. 23(4): p. 380-392.
240. Palivan, C.G., et al., Bioinspired polymer vesicles and membranes for biological 
and medical applications. Chem Soc Rev, 2016. 45(2): p. 377-411.
241. Mayer-Wagner, S., et al., Scaffold-free 3D cellulose acetate membrane-based 
cultures form large cartilaginous constructs. J Tissue Eng Regen Med, 2011. 
5(2): p. 151-5.
242. Ehgartner, J., et al., Low cost referenced luminescent imaging of oxygen and 
pH with a 2-CCD colour near infrared camera. Analyst, 2014. 139(19): p. 4924-
33.
243. Ungerbock, B., et al., Microfluidic oxygen imaging using integrated optical 
sensor layers and a color camera. Lab Chip, 2013. 13(8): p. 1593-601.
244. Shen, Y., et al., Integrins-FAK-Rho GTPases pathway in endothelial cells sense 
and response to surface wettability of plasma nanocoatings. ACS Appl Mater 
Interfaces, 2013. 5(11): p. 5112-21.
245. Hu, J., et al., Enhanced cell adhesion and alignment on micro-wavy patterned 
surfaces. PLoS One, 2014. 9(8): p. e104502.
246. Zhang, S., et al., Biological surface engineering: a simple system for cell pattern 
formation. Biomaterials, 1999. 20(13): p. 1213-20.
247. Hatano, R., et al., Endothelial cells derived from embryonic stem cells respond 
to cues from topographical surface patterns. J Biol Eng, 2013. 7: p. 18.
248. Tennant, M. and J.K. McGeachie, Blood vessel structure and function: a brief 
update on recent advances. Aust N Z J Surg, 1990. 60(10): p. 747-53.
References
130
249. Tanabe, S. and D. Grenier, Endothelial cell/macrophage cocultures as a model 
to study Streptococcus suis-induced inflammatory responses. FEMS Immunol 
Med Microbiol, 2009. 55(1): p. 100-6.
250. Lin, T.M., et al., Monocyte-endothelial cell coculture enhances infection of 
endothelial cells with Chlamydia pneumoniae. J Infect Dis, 2000. 181(3): p. 
1096-100.
251. Wada, Y., et al., In vitro model of atherosclerosis using coculture of arterial wall 
cells and macrophage. Yonsei Med J, 2000. 41(6): p. 740-55.
252. Islam, K., et al., Co-culture Methods Used to Model Atherosclerosis In Vitro 
Using Endothelial, Smooth Muscle and Monocyte Cells. SM J Biomed Eng, 
2016. 2(1).
253. Pergola, C., et al., Modulation of actin dynamics as potential macrophage 
subtype-targeting anti-tumour strategy. Sci Rep, 2017. 7: p. 41434.
254. Lilly, B., We have contact: endothelial cell-smooth muscle cell interactions. 
Physiology (Bethesda), 2014. 29(4): p. 234-41.
255. Fillinger, M.F., et al., Coculture of endothelial cells and smooth muscle cells in 
bilayer and conditioned media models. J Surg Res, 1997. 67(2): p. 169-78.
256. Williams, C. and T.M. Wick, Endothelial cell-smooth muscle cell co-culture in a 
perfusion bioreactor system. Ann Biomed Eng, 2005. 33(7): p. 920-8.
257. Chiu, J.J., et al., A model for studying the effect of shear stress on interactions 
between vascular endothelial cells and smooth muscle cells. Journal of 
Biomechanics, 2004. 37(4): p. 531-539.
258. Heydarkhan-Hagvall, S., et al., Co-culture of endothelial cells and smooth 
muscle cells affects gene expression of angiogenic factors. J Cell Biochem, 
2003. 89(6): p. 1250-9.
259. Truskey, G.A., Endothelial Cell Vascular Smooth Muscle Cell Co-Culture Assay 
For High Throughput Screening Assays For Discovery of Anti-Angiogenesis 
Agents and Other Therapeutic Molecules. Int J High Throughput Screen, 2010. 
2010(1): p. 171-181.
260. Hergenreider, E., et al., Atheroprotective communication between endothelial 
cells and smooth muscle cells through miRNAs. Nat Cell Biol, 2012. 14(3): p. 
249-56.
261. Boon, R.A., E. Hergenreider, and S. Dimmeler, Atheroprotective mechanisms 
of shear stress-regulated microRNAs. Thromb Haemost, 2012. 108(4): p. 616-
20.
262. Armulik, A., A. Abramsson, and C. Betsholtz, Endothelial/pericyte interactions. 
Circ Res, 2005. 97(6): p. 512-23.
263. Armulik, A., G. Genove, and C. Betsholtz, Pericytes: developmental, 
physiological, and pathological perspectives, problems, and promises. Dev Cell, 
2011. 21(2): p. 193-215.
264. Fisher, M., Pericyte signaling in the neurovascular unit. Stroke, 2009. 40(3 
Suppl): p. S13-5.
265. Raasch, M., et al., Microphysiological systems meet hiPSC technology - New 
tools for disease modeling of liver infections in basic research and drug 
development. Adv Drug Deliv Rev, 2018.
266. Orlova, V.V., et al., Generation, expansion and functional analysis of endothelial 
cells and pericytes derived from human pluripotent stem cells. Nature Protocols, 
2014. 9: p. 1514.
References
131
267. Dash, B.C., et al., Induced pluripotent stem cell-derived vascular smooth muscle 
cells: methods and application. The Biochemical journal, 2015. 465(2): p. 185-
194.
268. Shamis, Y., et al., Fibroblasts derived from human pluripotent stem cells activate 
angiogenic responses in vitro and in vivo. PLoS One, 2013. 8(12): p. e83755.
269. Rufaihah, A.J., et al., Human induced pluripotent stem cell-derived endothelial 
cells exhibit functional heterogeneity. American journal of translational research, 
2013. 5(1): p. 21-35.
270. Rosa, S., et al., Functional characterization of iPSC-derived arterial- and 
venous-like endothelial cells. Scientific Reports, 2019. 9(1): p. 3826.
271. Campbell, H.K., J.L. Maiers, and K.A. DeMali, Interplay between tight junctions 
& adherens junctions. Exp Cell Res, 2017.
272. Honda, H., The world of epithelial sheets. Dev Growth Differ, 2017.
273. Campanale, J.P., T.Y. Sun, and D.J. Montell, Development and dynamics of cell 
polarity at a glance. J Cell Sci, 2017. 130(7): p. 1201-1207.
274. Butler, M.T. and J.B. Wallingford, Planar cell polarity in development and 
disease. Nat Rev Mol Cell Biol, 2017.
275. Kwan, K.M., Coming into focus: the role of extracellular matrix in vertebrate optic 
cup morphogenesis. Dev Dyn, 2014. 243(10): p. 1242-8.
276. Livesey, F.J. and C.L. Cepko, Vertebrate neural cell-fate determination: lessons 
from the retina. Nat Rev Neurosci, 2001. 2(2): p. 109-18.
277. Hagios, C., A. Lochter, and M.J. Bissell, Tissue architecture: the ultimate 
regulator of epithelial function? Philos Trans R Soc Lond B Biol Sci, 1998. 
353(1370): p. 857-70.
278. Camazine, S., Self-organization in biological systems. Princeton studies in 
complexity. 2001, Princeton, N.J.: Princeton University Press. viii, 538 p., 8 p. 
of plates.
279. Bettahalli, N.M., et al., Development of multilayer constructs for tissue 
engineering. J Tissue Eng Regen Med, 2014. 8(2): p. 106-19.
280. Hogrebe, N.J., J.W. Reinhardt, and K.J. Gooch, Biomaterial microarchitecture: 
a potent regulator of individual cell behavior and multicellular organization. J 
Biomed Mater Res A, 2017. 105(2): p. 640-661.
281. Amenta, P.S. and D. Harrison, Expression and potential role of the extracellular 
matrix in hepatic ontogenesis: a review. Microsc Res Tech, 1997. 39(4): p. 372-
86.
282. Yonemura, S., Differential sensitivity of epithelial cells to extracellular matrix in 
polarity establishment. PLoS One, 2014. 9(11): p. e112922.
283. de Clerck, Y.A. and P.A. Jones, The effect of ascorbic acid on the nature and 
production of collagen and elastin by rat smooth-muscle cells. Biochem J, 1980. 
186(1): p. 217-25.
284. Tsuda, Y., et al., The use of patterned dual thermoresponsive surfaces for the 
collective recovery as co-cultured cell sheets. Biomaterials, 2005. 26(14): p. 
1885-1893.
285. Harimoto, M., et al., Novel approach for achieving double-layered cell sheets 
co-culture: overlaying endothelial cell sheets onto monolayer hepatocytes 




286. Chen, G., et al., Application of the cell sheet technique in tissue engineering. 
Biomed Rep, 2015. 3(6): p. 749-757.
287. Sakaguchi, K., T. Shimizu, and T. Okano, Construction of three-dimensional 
vascularized cardiac tissue with cell sheet engineering. J Control Release, 
2015. 205: p. 83-8.
288. Lee, P.J., P.J. Hung, and L.P. Lee, An artificial liver sinusoid with a microfluidic 
endothelial-like barrier for primary hepatocyte culture. Biotechnol Bioeng, 2007. 
97(5): p. 1340-6.
289. Groger, M., et al., Monocyte-induced recovery of inflammation-associated 
hepatocellular dysfunction in a biochip-based human liver model. Sci Rep, 2016. 
6: p. 21868.
290. Thomas, L., et al., Selective upregulation of TNF alpha, expression in 
classically-activated human monocyte-derived macrophages (M1) through 
pharmacological interference with V-ATPase. Biochemical Pharmacology, 
2017. 130: p. 71-82.
291. Zheng, W., et al., An Early-Stage Atherosclerosis Research Model Based on 
Microfluidics. Small, 2016. 12(15): p. 2022-34.
292. Pastorelli, L., et al., Central role of the gut epithelial barrier in the pathogenesis 
of chronic intestinal inflammation: lessons learned from animal models and 
human genetics. Front Immunol, 2013. 4: p. 280.
293. Balzan, S., et al., Bacterial translocation: overview of mechanisms and clinical 
impact. J Gastroenterol Hepatol, 2007. 22(4): p. 464-71.
294. Matthay, M.A. and G.A. Zimmerman, Acute lung injury and the acute respiratory 
distress syndrome: four decades of inquiry into pathogenesis and rational 
management. Am J Respir Cell Mol Biol, 2005. 33(4): p. 319-27.
295. Abaci, H.E. and M.L. Shuler, Human-on-a-chip design strategies and principles 
for physiologically based pharmacokinetics/pharmacodynamics modeling. 
Integr Biol (Camb), 2015. 7(4): p. 383-91.
296. Skardal, A., T. Shupe, and A. Atala, Organoid-on-a-chip and body-on-a-chip 
systems for drug screening and disease modeling. Drug Discov Today, 2016. 
21(9): p. 1399-411.





1. MOTiF biochip design supports EC culture and precise modulation of key physiologic 
parameters such as shear forces, mechanical stretch and nutritional supply
2. ECs benefit from improved perfusion conditions in MOTiF biochips in terms of 
morphology and maintaining their functionality
3. Spatially adjustable gradient concentrations enable endothelial cell barrier modulation 
and monitoring of immune cell recruitment 
4. Microphysiologic systems simulate mechanomodulatory cues that influence the 
behaviour of NPs
5. Tissue resident macrophages modulate EC biology and have a profound impact on NP 
uptake behaviour.
6. The MOTiF biochip provides a new tool to investigate processes of neuro-inflammation 
and neocortex formation, e.g. within drug screening and toxicity studies
7. A microphysiologic model of the human BBB within MOTiF biochips allows the 
investigation of GSH functionalized nanocarriers for gene delivery
8. Microphysiologic systems bare the possibility to simulate the microenvironmental 
human in vivo situation more accurately. This new approach may help to bridge the 
gap between in vitro experiments, animal models and the human in vivo situation.
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